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Abstract 
Alongside several well-known modifications in DNA and proteins, more than 100 different 
types of chemical modification are also found in cellular RNAs. RNA modifications can 
influence the secondary structure and interactions of the RNAs that carry them and they 
can therefore play important roles in regulating the functions of the RNAs. For many RNA 
modifications, the enzymes that introduce them are known but the modification targets of 
several predicted modification enzymes remain to be identified. Interestingly, a particular 
modification, N6-methyladenosine (m6A), was recently found to be reversible and a group 
of proteins, termed “readers” that can recognise the modification often via a specialised 
RNA binding domain (YTH domain), have been identified. Such “reader” proteins have 
been shown to regulate the fate of RNAs according to their modification status, 
suggesting that this so called “epitranscriptome” is an additional layer of regulation of 
gene expression.  
In this study, cross-linking and analysis of cDNA (CRAC) was used to identify the RNA-
interactome of the five human YTH domain-containing proteins, YTHDF1, YTHDF2, 
YTHDF3, YTHDC1, YTHDC2. To facilitate the mapping of the deep sequencing data 
obtained from CRAC experiments performed in human cells, a bioinformatic pipeline was 
adapted and further developed. Analysis of the CRAC data showed that YTHDF1, 
YTHDF2, YTHDF3 and YTHDC1 predominantly cross-link to mRNAs, which is in line 
with recently published reports describing functions for these proteins in mRNA 
degradation, alternative pre-mRNA splicing and enhancing mRNA translation. 
Interestingly, the CRAC analysis of YTHDC2 revealed a specific cross-linking site on the 
18S ribosomal RNA and the association of this protein with ribosomal complexes was 
confirmed by independent experimental approaches. CRAC analysis using truncated 
versions of YTHDC2 suggested that the R3H RNA binding domain is required for stable 
association of this protein with the ribosome and in vitro anisotropy experiments 
demonstrated that the YTH domain of YTHDC2 has a higher affinity for m6A 
modifications present in the sequence context found in the ribosomal RNAs than the 
classical m6A consensus motif found in many mRNAs. Interestingly, immunoprecipitation 
experiments followed by mass spectrometry identified the cytoplasmic 5’-3’ exonuclease 
XRN1 as an interaction partner of YTHDC2. These data could suggest a model in which 
recognition of the m6A modification(s) on the ribosomal RNA by the YTH domain of 
YTHDC2 promotes RNA degradation by XRN1. Taken together, this study contributes to 
the understanding of the diverse functions that modification “reader” proteins can play in 
regulating RNA metabolism. 
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1 Introduction 
1.1 RNA modifications 
Since the 1970s it has been known that RNA can be modified and the knowledge of RNA 
modifications has continually increased since (Rottman et al., 1974; Schibler et al., 1977; 
Wei et al., 1975, 1976; Wei and Moss, 1977). So far, about 150 different RNA 
modifications are known in all kingdoms of life, spanning all major classes of RNA in the 
cell (Machnicka et al., 2013). The most modified RNAs in the cell are transfer (t)RNAs, 
followed by the extensively modified ribosomal (r)RNAs. RNA modifications are known to 
affect the structural stability and folding of RNA, leading to the degradation of misfolded 
or aberrant RNA if important modifications are missing. In addition, translation can be 
fine tuned by modifications on tRNAs that influence the decoding of cognate messenger 
(m)RNA codons, and rRNA modifications that can influence the translation efficiency and 
fidelity of the ribosome. Modifications in mRNA can influence the stability of mRNAs and 
thereby also affect translation efficiency. Among the myriad of RNA modifications, the 
most common modifications are the addition of a methyl-group to various positions of the 
base and on the ribose, and pseudouridination of uridines. Less common modifications 
are, for example, acetylations, geranylations, wybutosine or carbamylation, which can be 
found in tRNAs (and rRNAs in the case of acetylation). RNA modifications have 
essential, but highly variable functions in the cell, forming an additional layer of regulation 
in gene expression termed the epitranscriptome.  
1.2 tRNA modifications 
1.2.1 tRNA biogenesis and function 
During translation of the mRNA by the ribosome, tRNAs serve as adapter molecules that 
translate the mRNA sequence into the amino acid sequence of the protein. Extensive 
and highly regulated RNA-RNA interactions between the tRNA, the codon triplet of the 
mRNA and the ribosome ensure the correct selection of the tRNA and incorporation of 
the correct amino acid into the nascent polypeptide chain by the ribosome (Demeshkina 
et al., 2010). 
However, the delivery of aminoacyl-residues to the ribosome during translation is not the 
only function of amino-acyl tRNAs and additional roles in the cell have been described. 
For example, tRNAs are required for the addition of destabilizing amino acids to the  
N-terminus of proteins to facilitate their turnover in the N-end rule pathway. Targeted 
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endonucleolytic cleavage at the codon loop divides the tRNA in half, forming stable 
fragments, which are proposed to have regulatory and signalling functions or are 
involved in the response to HIV-infection (Banerjee et al., 2010; Nawrot et al., 2011; 
Yeung et al., 2009). 
In Saccharomyces cerevisiae, a total of 275 tRNA genes are transcribed by RNA 
polymerase (RNAP) III (Chan and Lowe, 2009). The nascent transcript includes a  
5’ leader sequence, a 3’ trailer sequence and can contain an intronic sequence, which 
needs to be removed during biogenesis. Removal of the leader sequence by RNase P 
precedes the removal of the trailer sequence by RNase Z after nucleotide 73. The 3’ end 
is further processed by the addition of a CCA sequence by the nucleotidyltransferase 
Cca1 (TRNT1 in human cells) (Aebi et al., 1990). tRNAs are exported by Los1 (XPO-T in 
human cells), which also serves as a quality control step by sensing correct tertiary 
structure and end processing of the tRNA (Arts et al., 1998; Lipowsky et al., 1999; Lund 
and Dahlberg, 1998; Sarkar and Hopper, 1998). 61 tRNA genes contain introns, which 
are removed (often referred to as tRNA splicing) by the conserved family of Sen proteins 
either after export at the surface of mitochondria in yeast, or prior to export in the 
nucleoplasm in vertebrates (Lund and Dahlberg, 1998; Melton et al., 1980; Yoshihisa et 
al., 2003). tRNAs can undergo retrograde import into the nucleus, either for temporary 
storage or for further maturation. Finally, aminoacylation of tRNAs by 
aminoacylsynthetases takes place either in the nucleus after retrograde import or directly 
in the cytoplasm after maturation (Grosshans et al., 2000; Lund and Dahlberg, 1998; 
Steiner-Mosonyi and Mangroo, 2004). An overview of the pathway is shown in Figure 1A. 
The extensive modification of tRNAs is achieved by the addition of modifications 
throughout the whole maturation pathway (Figure 1B). The first modifications are directly 
added to the nascent transcript and further modifications are added in the nucleus and 
the cytoplasm (Hopper, 2013). The timing of some tRNA modifications is determined by 
the localisation of the enzymes that introduce them while other tRNA modification 
enzymes recognise specific features of the tRNA, e.g. introns or the 3’-CAA and can only 
modify the tRNA at a particular stage during its maturation (Grosjean et al., 1997). 
Modifications are necessary for the correct folding of tRNAs into the canonical clover leaf 
secondary structure with the acceptor stem and the D-loop, the TΨC-loop, the anticodon-
loop and the variable loop resembling the four parts of the leaf. The tertiary structure of 
tRNAs is an inverted L-shaped structure with the anticodon-loop at the bottom and the 
CCA-acceptor stem at the top (Shi and Moore, 2000). In addition, tRNA modifications are 
involved in codon recognition as well as tRNA stability, as described in the next chapter.  
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Figure 1: tRNA biogenesis and modifications. A Schematic overview of transfer (t)RNA biogenesis in 
yeast. tRNA biogenesis starts with the transcription of pre-tRNAs in the nucleus by RNAP III, followed by end 
processing and modification of the RNA. After export, introns are removed on the surface of mitochondria 
and further modifications are installed. The tRNAs either undergo aminoacylation and are primed for 
translation or they undergo retrograde import. Modifications are indicated as coloured circles: 
Early modifications are shown in pink, “pre-splicing” modifications are displayed in green and “post-splcing” 
modifications are shown in red. Abbreviations: Cyt, cytoplasm; Nuc. nucleus; NPC, nuclear-pore-complex. 
Modified from Sloan et al. (2016). B Overview of chemical modifications found in cytoplasmic tRNAs in yeast. 
A tRNA structure is shown in the cloverleaf representation. Residues that are unmodified in all tRNAs are 
shown in green, residues that are modified in some or all tRNAs are shown in pink, and white residues 
represent additional residues that are present in some tRNA species, which can also carry modifications. 
The anticodon loop is coloured in red and is also sometimes modified. The CCA end is shown in light blue. 
From Phizicky and Hopper (2010). 
1.2.2 Different types of tRNA modifications and their function 
Numerous different modifications are found in tRNAs. Together, over 100 chemically 
unique modifications are found in tRNAs in all three domains of life, of which 18 are 
universally present (Jackman and Alfonzo, 2013). However, many of these chemical 
modifications are also found in other types of RNA in the cell, although the enzymes that 
install them are often different (Phizicky and Hopper, 2010). tRNAs are also the most 
extensively modified RNA in the cell. Approximately, 17 % of the residues are modified, 
which is ten times more than in rRNA (Jackman and Alfonzo, 2013).  
In general, tRNA modifications can be sorted into two categories based on their position 
within the tRNA. Modifications in the anti-codon loop often affect codon recognition and 
therefore synthesis of proteins, whereas modifications in the main body are frequently 
connected to tRNA stability.  
Modifications in the anti-codon loop are often found at position 34, which is called the 
“wobble position”. The genetic code is degenerate meaning that multiple codons code for 
the same amino acid, because the number of codons exceeds the number of amino 
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acids. This results in the fact that for the decoding of many codons, the nucleotide at the 
third position is flexible and the corresponding tRNA is required to recognise multiple 
different nucleotides at this position. This flexibility can be achieved by modifications at 
the wobble position of the tRNA. A well-studied example of a wobble position 
modification that affects translation is the deamination of adenine to inosine by the RNA-
dependent adenosine deaminases Tad2 and Tad3 (Gerber and Keller, 1999). The 
conversion to inosine leads to an increased base-pairing capability with cytidine and 
adenine in addition to the conventional base-pairing with uracil. The lack of these 
modification leads to decoding errors during translation. Many other modifications, such 
as 5-methylcytosine (m5C) and 5-methoxycarbonylmethyl-2-thiouridine, are also found at 
position 34 of tRNA and similarly function to influence the decoding capacity of the 
tRNAs that carry them (reviwed in Ranjan and Rodnina, 2016).  
Modifications in the body of the tRNA are commonly connected to structural stability by 
defining either more loose or rigid parts of the tRNA. Several studies showed that loss of 
certain modifications can lead to increased instability of mature tRNAs and the 
generation of tRNA fragments, for example during heat stress (Alexandrov et al., 2006; 
Dewe et al., 2012; Kotelawala et al., 2008). However, also the initial folding of tRNAs can 
be affected by modifications and single modifications can promote the correct folding of 
tRNAs (reviewed in Motorin and Helm, 2010).  
Loss of tRNA modifications or mutations in tRNA modifying enzymes have been 
connected to a variety of human diseases, including neurological and metabolic diseases 
and cancer (reviewed in Torres et al., 2014). It has been suggested that the molecular 
connection between these diseases and tRNA modifications can be based on perturbed 
protein synthesis due to the inefficient reading of certain codons, however, the molecular 
basis of many diseases is not known. However, it could be shown that the lack of 
ms2t6A37 in the tRNALys leads to the production of aberrant proinsulin, thus impeding the 
processing to insulin and causing type II diabetes.  
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1.3 Ribosomal RNA modifications 
1.3.1 Biogenesis and function of ribosomes 
The ribosome is the protein synthesis machine of the cell and contains four ribosomal 
(r)RNAs and approximately 80 ribosomal proteins (Anger et al., 2013; Ben-Shem et al., 
2011). These are asymmetrically organised in a large and a small ribosomal subunit 
(SSU and LSU). The 18S rRNA is part of the SSU, whereas the 25S (yeast)/28S 
(humans), 5.8S and 5S rRNAs form the core of the LSU. Interestingly, the proteins solely 
function as a scaffold for stabilising the rRNA and do not have an enzymatic activity 
(Simonovic and Steitz, 2009). Thus, the ribosome is a large ribozyme because the rRNA 
is responsible for providing the catalytic enzymatic activity. The ribosome has two major 
functions, firstly providing a framework for the translation and secondly, enabling 
formation of the peptide bond. The mRNA decoding centre is located in the SSU 
providing a scaffold for high fidelity decoding (Demeshkina et al., 2012). The LSU on the 
other hand contains the peptidyl transferase centre (PTC), which is responsible for the 
introduction of peptide bonds connecting single amino acids to form nascent peptides 
(Ben-Shem et al., 2011; Simonovic and Steitz, 2009). Notably, these two functionally 
important sites are conserved in all kingdoms of life, while other regions of the ribosome 
are more variable (Armache et al., 2013; Ban et al., 2014; Melnikov et al., 2012; Wilson 
and Doudna Cate, 2012). These include so called eukaryotic extensions, which are 
stretches of rRNA specifically found in eukaryotic ribosomes, which are thought to enable 
the translation of more complex mRNAs in higher eukaryotes and might also have 
regulatory functions. 
Ribosome biogenesis is one of the major energy consuming pathways in the cell 
(reviewed in Henras et al., 2015; Woolford and Baserga, 2013). In a rapidly dividing 
yeast cell 2,000 ribosomes are produced per minute leading to the synthesis of 200,000 
ribosomes per generation (Warner, 1999). The rRNA represents approximately 80 % of 
the total cellular RNA and 60 % of mRNA transcripts are related to ribosome biogenesis. 
All three RNA-Polymerases (RNAP) are involved in this process. It starts with the 
transcription of a precursor (pre-)rRNA (47S in humans and 35S in yeast) by RNAPI from 
the rDNA repeats. In human cells, the repeats are localised at the short arms of the five 
acrocentric chromosomes HSA-13, 14, 15, 21 and 22 (Worton et al., 1988). The 47S pre-
rRNA contains the sequences of the 18S, 5.8S and 28S rRNAs, separated by internal 
transcribed spacers (ITS1 and ITS2) and external transcribed spacers (5’ ETS and 
3’ ETS). Ribosome biogenesis factors bind co-transcriptionally to the 47S rRNA 
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Figure 2: Ribosome biogenesis and rRNA modifications. A Schematic overview of ribosome biogenesis 
in human cells. Maturation of the ribosomal subunits is shown from left to right, starting with the transcription 
of the 47S pre-ribosomal (r)RNA from the rDNA repeat by RNAP I and assembly of the 90S pre-ribosomal 
complexes. The 5S rRNA is transcribed independently by RNAP III and joins the pre-60S (large ribosomal 
subunit) complex (blue) in the nucleolus as part of the 5S RNP. After a central cleavage step, pre-60S 
subunit and pre-40S (small ribosomal) subunit (green) maturation continues separately. During this process, 
numerous ribosome biogenesis factors, indicated by coloured shapes, transiently interact with the pre-
ribosomal subunits. The pre-ribosomal subunits are exported and final maturation steps occur in the 
cytoplasm. Cellular compartments are indicated at the top. Abbreviations: RNAP I, RNA polymerase I; RNAP 
III, RNA polymerase III; RNP, ribonucleoprotein particle. Adapted from Gerhardy et al. (2014). B 3D structure 
of the human ribosome (PDB 4V6X, Anger et al., 2013). The ribosomal RNA is depicted in grey cartoon 
model representation and ribosomal proteins are shown as light blue in the background. The positions of the 
base modifications are shown by red spheres, and the type of modification and the modified residue are 
indicated. Pseudouridinations and 2’-O-methylations are marked on the rRNA in magenta and green, 
respectively. The positions of functionally important regions of the ribosome such as the peptidyl transferase 
centre (PTC) and decoding site (DCS) are indicated. 
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forming the 90S pre-ribosome in the nucleolus (reviewed in Kornprobst et al., 2016; 
Tschochner and Hurt, 2003). The 5S rRNA is transcribed separately by RNAPIII and is 
incorporated into the pre-ribosome in complex with the ribosomal proteins RPL5 (uL18) 
and RPL11 (uL5) (reviewed in Ciganda and Williams, 2011). After a central pre-rRNA 
cleavage step, the 90S pre-ribosome is separated into the 60S pre-ribosomal complex 
(pre-LSU) and the 40S pre-ribosomal complex (pre-SSU) (Figure 2A, Henras et al., 2015; 
Sloan et al., 2013; Thomson et al., 2013; Woolford and Baserga, 2013). These mature 
independently while transported through the nucleoplasm constantly swapping ribosome 
biogenesis factors (reviewed in Gerhardy et al., 2014). Final maturation steps occur in 
the cytoplasm after the pre-SSU and pre-LSU particles are separately exported to the 
cytoplasm (Lebaron et al., 2012; Sloan et al., 2016). More than 200 co-factors are 
involved in processing and modifying of the rRNA and assembly of the ribosomal 
subunits (Gasse et al., 2015; Sharma and Lafontaine, 2015; Sloan et al., 2015;  
Sloan et al., 2013; Watkins and Bohnsack, 2012; Woolford and Baserga, 2013). Endo- 
and exo-nucleases are involved in the removal of the spacer fragments, whereas 
methyltransferases and pseudouridine synthases introduce the majority of the rRNA 
modifications. RNA helicases are involved in remodelling of RNA-RNA and RNA-protein 
interactions in concert with ATPases and GTPases, which introduce conformational 
changes to the pre-ribosome.  
1.3.2 snoRNA-guided modifications 
The rRNA modifications can be classified into snoRNA-guided modifications and base-
modifications based on their location on the nucleotide. Backbone modifications are the 
most abundant modifications on the rRNA and can be further sub-divided into  
2’-O-methylations and pseudouridinations. 55 2’-O-methylations and 45 pseudouridines 
are found in yeast rRNA, whereas approximately 100 2’-O-methylations and 100 
pseudouridines are found in human rRNA (Birkedal et al., 2015; Krogh et al., 2016; 
Lestrade and Weber, 2006; Piekna-Przybylska et al., 2008a; Taoka et al., 2016). These 
modifications are mostly introduced by small nucleolar ribonucleoprotein complexes 
(snoRNPs), which consist of a small nucleolar (sno)RNA and four core proteins 
(reviewed in Watkins and Bohnsack, 2012). The snoRNA guides the complex to the site 
of modification by forming base-paring interactions with the pre-rRNA. The proteins of the 
complex also establish further pre-rRNA interactions and provide the enzymatic activity 
of the complex. 2’-O-methylations or pseudouridines are introduced either by Box C/D 
snoRNPs, which contain the methyltransferase Fibrillarin (yeast Nop1) or H/ACA 
snoRNPs that contain the pseudouridine synthase Dyskerin (yeast Cbf5). Interestingly, in 
bacteria 2’-O-methylation and pseudouridine modifications are not introduced by 
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snoRNPs but by standalone methyltransferases or pseudouridine synthases, meaning a 
separate enzyme is required for each of the 14 backbone modifications (Popova and 
Williamson, 2014). The switch to a modular system with constant protein components 
and a flexible guide-snoRNA makes the system much more efficient for 100-200 different 
modifications in eukaryotes.  
1.3.3 Base modifications 
Interestingly, from bacteria to lower eukaryotes and further on to humans the ratio of 
modifications shifts from primarily base modifications to mainly backbone modifications. 
In bacterial rRNA, the majority are base modifications, whereas in yeast rRNA the 
amount drops to approximately 10 % (12 of 112 in total), which further decreases to 5 % 
(11 of >200 in total) in human rRNA. This reduction is mainly due to an increase in  
2’-O-methylations and pseudouridinations suggesting that most base modifications are 
important and therefore conserved (Piekna-Przybylska et al., 2008a; Popova and 
Williamson, 2014; Sharma and Lafontaine, 2015). 
Seven different types of base modifications are found in yeast rRNA. Half of the 12 base 
modifications are found in the SSU and half in the LSU in yeast. All six SSU 
modifications are conserved in humans, while only three of the six LSU base 
modifications are conserved (Figure 2B, Sharma and Lafontaine, 2015). Notably, except 
for one, the individual modifications are not essential for cell growth in yeast, however, 
several of the modifying enzymes are essential or lead to impaired growth, meaning that 
only the presence of the enzymes is important for ribosome biogenesis (Sharma and 
Lafontaine, 2015). In yeast, the enzymes responsible for the modifications are all known: 
nine stand-alone methyltransferases and one aminocarboxypropyl (acp) transferase. 
The 18S rRNA of the SSU contains a hypermodified uridine, m1acp3Ψ, at position 1191. 
The first step in this modification pathway is a pseudouridylation guided by the snoRNA 
snR35, which was shown to be not essential but deletion strains show a growth defect 
(Liang et al., 2009). In the second step, the SPOUT class methyltransferase Emg1/Nep1 
introduces the N1-methylation to the base of the pseudouridine (Leulliot et al., 2008; 
Wurm et al., 2010). SPOUT class methyltransferases use S-adenosyl-methionine (SAM) 
as the source of the methyl group that is transferred (Tkaczuk et al., 2007). The last step 
takes place in the cytoplasm and is catalysed by the acp-transferase Tsr3, which 
interestingly also resembles a SPOUT class methyltransferases. However, instead of the 
methyl group of SAM, the acp-group is transferred to the substrate (Meyer et al., 2016). 
This m1acp3Ψ hypermodification is conserved in human rRNA and the human orthologue 
of Emg1 was shown to complement the function in yeast and knockdown of human Tsr3 
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was shown to reduce the modification in vivo (Eschrich et al., 2002; Liu and Thiele, 2001; 
Meyer et al., 2016). The eukaryotic specific acetylations of 18S-ac4C1280 and 18S-ac4C1773 
are both introduced by the ATP and acetyl-CoA dependent acetylases Kre33 in yeast 
and NAT10 (ac4C1337, ac4C1842) in human cells (Ito et al., 2014a; Ito et al., 2014b; Sharma 
et al., 2015). The yeast modification 18S-m7G1575 is installed by Bud23 together with 
Trm112, and is conserved in humans, where WBSCR22 together with TRMT112 are 
responsible for this modification (Haag et al., 2015a; White et al., 2008). Despite the fact 
that the methyltransferase activity of Bud23/WBSCR22 is not essential, the proteins are 
required for ribosome biogenesis and for the efficient export of the 40S subunits in yeast 
and humans (Haag et al., 2015a; White et al., 2008; Zorbas et al., 2015). The only  
di-methylations in rRNA are the two 18S-m26A1781, 18S-m26A1782 modifications, which are 
conserved from bacteria to eukaryotes. In yeast, the modifying di-methyltransferase is 
Dim1 that joins the pre-ribosome in the nucleus, but installs the modification in the 
cytoplasm, whereas in human cells DIMT1L stays in the nucleus where also the 
modification takes place (Lafontaine et al., 1995; Zorbas et al., 2015).  
In the LSU, six mono-methylations are reported in yeast. All modifications are introduced 
by Rossmann-fold methyltransferases that use SAM as the methyl group donor  
(Sharma and Lafontaine, 2015). The m1A645 is conserved in higher eukaryotes and 
mediated by the ribosome biogenesis factor Rrp8 in yeast (Peifer et al., 2013).  
The second m1A2142 modification is introduced by Bmt2, as could be shown by mutation 
analysis (Sharma et al., 2013a). Unlike m1A645, m1A2142 is not conserved in human cells. 
Two m5C modifications can be found in yeast at position 2278 and 2870 of the 25S 
rRNA. They are installed by Rcm1 and Nop2, respectively (Sharma et al., 2013b).  
Both modifications are not essential, however, loss of m1A2142 leads to slow growth and 
Nop2, in contrast to Rcm1, is essential. The modifications are conserved in human and it 
was shown that human NSUN1 (p120) could complement a nop2Δ yeast strain and 
restore the m5C2870 modification, suggesting that it is the methyltransferase for m5C4447 in 
human rRNA (Bourgeois et al., 2015). It is suggested that the human homologue of 
Rcm1, NSUN5, is responsible for the corresponding human m5C3782 modification, but 
although this has not been directly proven, evidence from fruit flies and worms, as well as 
homology studies strongly supports this (Schosserer et al., 2015; Sharma et al., 2013b). 
Finally, the methyltransferases responsible for m3U2634 and m3U2843 were identified as 
Bmt5 and Bmt6 in yeast (Sharma et al., 2014). Also, one m3U4500 in 28S rRNA of human 
cells is reported, however, the methyltransferase responsible for this modification 
remains elusive (Piekna-Przybylska et al., 2008a). Compared to yeast, human rRNA has 
an additional type of modification; one modified N6-methyladenosine (m6A) residue at 
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position 1832 in the 18S rRNA and one at position 4220 in the 28S rRNA (Linder et al., 
2015; Piekna-Przybylska et al., 2008a). The modifying methyltransferases still need to be 
discovered. 
1.3.4 Functions of rRNA modifications 
In general, RNA modifications expand the chemical properties of nucleotides and thereby 
influence the functions of the RNAs that carry them. 2’-O-methylations of the ribose 
increase hydrophobicity and lead to enhanced hydrophobic interactions. This causes 
increased rigidity of the RNA by additional base stacking capabilities (Prusiner et al., 
1974). Pseudouridine is an isomerisation of the uracil ring resulting in additional 
hydrogen bond formation capabilities compared to uridine. This increases the thermal 
stability of the RNA by forming additional RNA-RNA interaction (Hayrapetyan, 2009).  
On the other hand, base modifications can have several effects, depending on their 
location on the base. They can increase base stacking as well as introduce a charge to 
the aromatic ring system, abrogate Watson-Crick base paring or introduce non canonical 
hydrogen bonding (Hayrapetyan, 2009). Introduction of a charge may also extend RNA-
protein interaction possibilities (Agris et al., 1986). 
In the ribosome, rRNA modifications cluster at functionally important regions, such as the 
PTC in the LSU, the decoding centre in the SSU and at the inter-subunit contact sites. 
These modifications are suggested to regulate the stability of the RNA and thereby 
enhance efficient and accurate translation by the ribosome. To achieve a high fidelity of 
the ribosome the single modifications work in concert, meaning that deletion of single 
modifications often does not affect translation, however, if several modifications are 
deleted, effects in translational fidelity can be detected (Gigova et al., 2014; King et al., 
2003). For example frame shifting and stop codon read-through is increased and tRNA 
incorporation is decreased when snoRNAs guiding clusters of modifications are deleted 
(Baudin-Baillieu et al., 2009; King et al., 2003; Liang et al., 2007, 2009). For example, an 
important modification cluster is located on a structure in the LSU called the A-site finger 
(helix 38) (Piekna-Przybylska et al., 2008b). This helix makes important contacts with the 
5S rRNA, tRNAs and also the SSU and is thought to function as an attenuator while 
moving the tRNA from the A- to the P-site during translation. Six pseudouridines are 
clustered there and three of them are conserved in eukaryotes. Depletion of two of the 
three modifications showed no significant effect, however, if all three were depleted, the 
cells displayed slower growth rates, lower LSU abundance and decreased translation. 
As mentioned above, lack of individual base modifications often does not have a 
significant effect on ribosome biogenesis, but lack of these modifications can have an 
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effect on translation fidelity. For example, expression of a catalytically inactive version of 
the RNA methyltransferase Dim1 leads to translation defects in vitro (Lafontaine 1998). 
Another example of a base modification that affects translation is m5C2278, introduced by 
Rcm1 (Schosserer et al., 2015). Loss of this modification leads to reduced translational 
fidelity and increased STOP codon read-through due to structural changes in the vicinity 
of the modification. 
Interestingly, modification sites on the rRNA are not all fully modified under normal 
growth conditions. Recent 2’-O-methylation profiling of the rRNA revealed that one third 
of the positions are only partially modified in human cells and studies in yeast similarly 
identified sites of partial modification (Birkedal et al., 2015; Buchhaupt et al., 2014;  
Krogh et al., 2016; Taoka et al., 2016). The extent of modification at specific positions 
may vary in different cells, supporting the concept of ribosome heterogeneity. Specialised 
ribosomes could translate a subset of mRNAs or are concentrated at different locations 
in the cytoplasm. Partial modifications might also have a regulatory function under 
different stress conditions and could also play a role in pathological settings, as several 
rRNA modifications and modifying enzymes are linked to human diseases. 
A variety of human disorders have been linked to defects in rRNA modifications or 
enzymes that install them. Altered snoRNA levels were found in haematological 
disorders like leukaemia and dyskeratosis congenital as well as in lung and prostate 
cancer (McMahon et al., 2015). For example, the Bowen-Conradi syndrome is caused by 
a mutation in the methyltransferase gene EMG1 and the genes encoding for the m7G 
and m5C methyltransferases WBSCR22 and NSUN5 are deleted in Williams-Beuren 
syndrome (Armistead et al., 2009; Doll and Grzeschik, 2001). 
1.4 Messenger RNA modifications 
The first publications of modifications in messenger (m)RNAs were published in the 
1970s with the identification of m6A and m5C (Dubin and Taylor, 1975; Schibler et al., 
1977). Due to methodical and technical limitations, the extent of modifications could not 
be detected at that time. With the emergence of new sequencing techniques further 
modifications could be identified, leading to the term “epitranscriptome” and based on the 
term epigenome (reviewed in Hoernes and Erlacher, 2016; Soshnev et al., 2016). So far, 
four modifications have been found in mRNAs; m6A, m5C, pseudouridine and  
N1-methyladenine (m1A). Since the m6A modification is discussed in detail in section 1.5, 
this section will focus on the other modifications found in mRNAs. In addition to these 
methylations and pseudouridylations, mRNA can undergo RNA editing, involving 
insertion or deletion of nucleotides, or alteration of cytosine to uridine or adenine to 
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inosine. Such RNA editing can change protein sequences by altering nucleotides of 
codons and potentially introducing additional STOP codons as well as influencing the 
differential expression of miRNAs (Chawla and Sokol, 2014; Powell et al., 1987). 
Beside its occurrence in tRNAs, rRNA and the well characterized function in transcription 
regulation on DNA, m5C is also present in mRNA in humans and archaea (Edelheit et al., 
2013; Squires et al., 2012). Next-generation sequencing together with bisulfide 
sequencing has allowed the transcriptome-wide mapping of m5C and its oxidation 
products 5-hydroxymethylcytidine (hm5C) and 5-formylcytidine (f5C) (Booth et al., 2013; 
Edelheit et al., 2013; Lee and Kim, 2016). In HeLa cells over 10,000 m5C modification 
sites were discovered in non-coding (nc)RNAs and mRNAs. Analysis of the distribution 
on mRNAs showed signals along the mRNA with an enrichment in 5’ and 3’ UTRs, 
suggesting a function in regulating protein translation (Squires et al., 2012). This is 
supported by experiments in fruit flies, which showed impaired brain development upon 
reduction of the hm5C modification and a positive correlation of m5C to hm5C conversion 
and translation was exhibited in vitro (Delatte et al., 2016). In human cells, the m5C 
content can also be regulated by oxidation to hm5C and f5C, implying that a similar 
mechanism may exist in mammals (Huber et al., 2015).  
Very recently m1A was discovered in mRNAs by making use of specific chemical 
properties of this modified nucleotide. Two parallel studies demonstrated the presence of   
m1A in mRNAs by using an antibody-based approach to pull down m1A containing 
sequences, followed by next-generation sequencing to map the modified nucleotides 
(Dominissini et al., 2016; Tserovski et al., 2016). During reverse transcription, m1A 
modifications introduce transcription stops represented by accumulation of 3’ ends that 
correlate with the modification sites. The presence of m1A in mRNAs and ncRNAs is 
conserved in eukaryotes from yeast to human and it is suggested that the modifications 
are often embedded in a GC rich sequence (Dominissini et al., 2016). The number of 
m1A-containing mRNAs is reported to range from over 800 (Li et al., 2016) to over 4,000 
(Dominissini et al., 2016) and the average methylation level of a single m1A-containing 
mRNA is approximately 20 % (Dominissini et al., 2016). The distribution of the m1A 
modification on mRNAs is still open to debate as one report suggests a bias towards the 
5’ end of mRNAs with an elevated abundance in 5’ UTRs, especially if they contain 
strong secondary structures, and an increase of m1A near the first splice site and the 
start codon (Dominissini et al., 2016), whereas the other report suggests an over 
representation of m1A modification in both the 5’ and 3’ UTRs (Li et al., 2016).  
However, both reports suggest a role for the modification in translation regulation as the 
methylation pattern was found to be altered in response to different physiological 
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conditions and external stresses (Dominissini et al., 2016; Li et al., 2016). In line with 
such a dynamic function, the modification was also found to be reversible by the alpha-
ketoglutarate-dependent dioxygenase ALKBH3 (Li et al., 2016). 
Next-generation sequencing has also enabled the transcriptome-wide mapping of 
pseudouridine. Similar to m1A, pseudouridine introduces a reverse transcription stop 
after treatment with the molecule CMC (Bakin and Ofengand, 1993; Zaringhalam and 
Papavasiliou, 2016). Pseudouridine was reported to be present in yeast and human 
mRNAs and ncRNAs (Carlile et al., 2014; Li et al., 2015a; Lovejoy et al., 2014). By mass 
spectrometry analysis, a high pseudouridine to uridine ratio of 0.2-0.6 % was found in 
human mRNA and depletion/deletion experiments showed that these modifications are 
installed by the conserved pseudouridine synthetases of the Pus family (Carlile et al., 
2014; Lovejoy et al., 2014; Schwartz et al., 2014a). Pseudouridylation has a high 
regulation potential because of its high abundance in mRNAs and indeed, it was shown 
that pseudouridylation is altered upon starvation induced stress in yeast and human cells 
(Carlile et al., 2014; Li et al., 2015a; Schwartz et al., 2014a). Different effects of the 
modification have also been observed on translation. In vitro assays using rabbit 
reticulocyte lysate and in vivo assays in mice and human cells show an increased 
translation rate and stability for pseudouridnated mRNAs (Kariko et al., 2008). The effect 
is the opposite in plant wheat germ extract and translation is completely abolished for 
multiple pseudouridinated mRNAs in E. coli lysate (Kariko et al., 2008). A second 
property of pseudouridine is the alteration of nonsense stop codons. Pseudouridination of 
UAA, UAG or UGA stop codons prevents the ribosome from recognising the stop codon 
and alternative amino acids are incorporated instead depending on the codon  
(Hoernes et al., 2016; Karijolich and Yu, 2011). 
Recent improvements in modification detection techniques have enabled the detection of 
modifications in mRNAs but still, of the myriad of possible RNA modifications only four 
could be identified in the mRNAs so far. Further improvements to detection methods will 
likely lead to the discovery of even more types of modifications in mRNAs.  
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1.5 N6-methyladenosine 
1.5.1 m6A in mRNA 
A series of reports in the 1970 for the first time reported N6-methyladenosine (m6A) in 
RNA (Rottman et al., 1974; Schibler et al., 1977). The invention of new techniques, 
especially the development of next-generation sequencing, allowed a more sensitive 
analysis and revealed the extent of this modification in the transcriptome. Antibodies 
were developed that specifically detect the m6A modification and this allowed, in 
combination with deep sequencing, the detection of m6A in cellular mRNA (Chen et al., 
2015; Dominissini et al., 2012). However, due to the approach used, the modifications 
could not be mapped to individual nucleotides, but only enabled the m6A modifications to 
be assigned to a 50-100 nucleotide region of specific mRNAs. Recently, the resolution 
was improved to single nucleotide level using specific mutational patterns of the m6A 
binding site introduced by the cross-linking method (Linder et al., 2015).  
Alternative mapping methods have since been developed to detect m6A modification 
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Figure 3: m6A is a dynamic modification. A Schematic representation of the methylation and 
demethylation reactions of the m6A modification. Methylation is accomplished in a one-step reaction, while 
demethylation can include several oxidative intermediates. The enzymes that mediate the different reactions 
are indicated. m6A modifications in RNAs can be specifically recognised by the YTH domains of specific 
proteins. YTH domain crystal structure (PDB 4RDN, Li et al., 2014). B Different possible conformational 
states of the methyl-group at N6. The syn conformation is energetically favoured, however, the anti 
conformation is adopted during Watson-Crick base paring in RNA double strands leading to steric 
interference of the methyl group with N7 of the purine ring. Modified from Roost et al., 2015. 
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sites independent of antibodies. Microarray based methods exploit altered base pairing 
properties of m6A compared to unmodified adenosine to detect the modification, however 
this approach is only suitable for highly enriched m6A sites (Li et al., 2015b).  
Similarly, site-specific cleavage and radioactive-labelling followed by ligation-assisted 
extraction and thin-layer chromatography (SCARLET) can be used to detect m6As at 
single nucleotide resolution, however, it is not suitable for high throughput approaches, 
as it can only be used to confirm known m6A sites in RNAs (Liu et al., 2013). 
Studies using these methods have revealed over 12,000 m6A sites in mRNAs and 
ncRNAs of over 7,000 human transcripts. Global positional analysis of m6A-containing 
mRNAs revealed an increase in m6A modifications around stop-codons, long internal 
exons and in the 3’ UTRs of mRNAs (Chen et al., 2015; Dominissini et al., 2012; Meyer 
et al., 2012). Furthermore, the GGACU motif was highly enriched in the data, resembling 
the formerly established consensus motif RRACH, which was already proposed in the 
1970’s by chromatographically isolation and paper sequencing of m6A-containing mRNA 
oligonucleotides (Chen et al., 2015; Dominissini et al., 2012; Meyer et al., 2012; Schibler 
et al., 1977). Former studies also found m6A in introns of mRNAs (Carroll et al., 1990). 
Notably, the m6A modification is universally present in mRNA of lower and higher 
eukaryotes like human, mouse, fruit fly and yeast (Dominissini et al., 2012; Hongay and 
Orr-Weaver, 2011; Schwartz et al., 2013). However, in yeast the m6A modification is 
limited to over 1,000 mRNAs, restricted to meiosis and suggested to be highly regulated 
(Schwartz et al., 2013). Also, it is reported to influence the translation of certain mRNA 
transcripts during meiosis (Bodi et al., 2015).  
The m6A modification can work as a molecular switch by changing the secondary 
structure of the RNA that can lead to the presentation of RNA binding motifs or structures 
for certain RNA binding proteins (Liu et al., 2016). The methyl group at position  
N6 of the adenine can accommodate either the syn or anti conformation (Figure 3B, 
Roost et al., 2015). The syn conformation has a lower energy and is the preferred 
position, because it avoids steric clashes with the purine ring of the base. However, 
during Watson-Crick base pairing, the syn conformation is not possible because it 
interferes with the hydrogen bonding network, thus pushing the methyl group in the less 
favoured anti conformation (Roost et al., 2015). This conformation has a higher energy 
and can destabilise duplexes in short double stranded regions. However, m6A also has 
increased base stacking capabilities leading to more stable single stranded structures, 
especially next to helices. Based on these findings a so-called ‘spring loaded 
mechanism’ is proposed, switching form double stranded to single stranded upon 
methylation.  
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On a cellular level the m6A modification has implications in stress response and is part of 
the circadian rhythm of cells (Fustin et al., 2013; reviewed in Hastings, 2013; Meyer et 
al., 2015). In mouse, the m6A modification was shown to affect the regulation of 
embryonic stem cells by keeping the omnipotence of the cells and might be involved in 
the cell cycle regulation in human cells (Dominissini et al., 2012; Wang et al., 2014b).  
1.5.2 m6A methyltransferases 
The m6A modification can be installed by a methylation complex comprised of the 
methyltransferase METTL3, the putative methyltransferase METTL14, and the regulatory 
proteins WTAP and KIAA1429 (Figure 3A, Liu et al., 2014; Ping et al., 2014; Schwartz et 
al., 2014b). Notably, other m6A methyltransferases might also be involved in introducing 
such modifications, because knockdown of individual components of the 
METTL3/METTL14 complex does not abolish m6A modification completely and the 
binding sites of the complex on cellular RNAs only partially overlap with the portion of the 
known m6A modification sites (Chen et al., 2015; Liu et al., 2014; Schwartz et al., 2014b). 
The regulatory protein WTAP seems to have an influence on the position of the 
methylation within the mRNA, because WTAP-independent modification sites are mainly 
found at the 5’ cap structure of mRNAs, whereas the installation of internal m6A sites 
requires WTAP (Schwartz et al., 2014b). Recent studies identified METTL3 as the main 
subunit responsible for the modification (Wang et al., 2016b; Wang et al., 2016c). 
Structural and biochemical analyses showed that METTL3 and METTL14 form a 
heterodimer by forming a large hydrogen bond interaction network, resulting in a 
positively charged groove for RNA-binding. Mutational analysis of the SAM binding 
pocket of both methyltransferases revealed that METTL3 is the active, catalytic subunit. 
This is supported by a crystal structure of the heterodimer, which showed that only the 
binding pocket of METTL3 contained SAM and was highly conserved among 
methyltransferases while the binding pocket of METTL14 only showed low conservation 
(Wang et al., 2016b; Wang et al., 2016c). It is proposed that METTL14 supports the 
methylation activity of METTL3 by stabilising the conformation of METTL3, leading to a 
higher activity (Wang et al., 2016b). Identification of the binding sites of METLL3 and 
METTL14 on cellular RNAs by CLIP and motif analysis has revealed a GGAC motif, 
which is identical to the m6A motif (Dominissini et al., 2012; Liu et al., 2014; Ping et al., 
2014). The proteins are conserved in human, mouse, zebrafish and drosophila, 
suggesting that this mechanism of m6A modification is conserved (Bokar et al., 1997;  
Liu et al., 2014; Ping et al., 2014; Schwartz et al., 2014b). 
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1.5.3 Oxidative demethylation 
Interestingly, m6A has been found to be a reversible modification (reviewed in Fu et al., 
2014). It is either removed directly or by oxidative demethylation via N6-
hydroxymethyladenosine (hm6A) or N6-formyladenosine (f6A) (Figure 3A). However, 
hm6A and f6A have a low stability under physiological conditions, displaying a half-life of 
only 3 h, which is very short compared to the half life of the m5C oxidation products f5C 
and hm5C, thus the physiological relevance of hm6A and f6A has to be confirmed  
(Fu et al., 2013). The enzymes implicated in demethylation are the human AlkB homolog 
5 (ALKBH5) and the fat mass and obesity-associated protein (FTO) (Jia et al., 2011; 
Zheng et al., 2013). Both proteins belong to the family of non-heme Fe(II)- and  
α-ketoglutarate-dependent dioxygenases. ALKBH5 directly demethylates m6A, whereas 
FTO uses the oxidative demethylation pathway (Figure 3A, Fu et al., 2013; Zheng et al., 
2013). In line with this, overexpression of FTO or ALKBH5 decreases the level of m6A in 
mRNAs, whereas depletion has the opposite effect (Jia et al., 2011; Zheng et al., 2013). 
Both proteins posses structural features that enable them to specifically target single 
stranded nucleic acids and to regulate substrate specificity, which is important to avoid 
demethylating DNA as they are both localised in the nucleus (Aik et al., 2014; Feng et al., 
2014; Han et al., 2010; Jia et al., 2011; Zheng et al., 2013; Zou et al., 2016).  
FTO is mainly expressed in neuronal tissue in mice and is associated with several 
diseases. Overexpression of FTO leads to increased food intake causing obesity in mice, 
mainly by increasing the body fat mass (Church et al., 2010). Studies with patients 
affected by a loss of function mutation on the fto gene showed severe growth retardation 
and multiple malformations of the body and defects in several organs, including the 
central nervous system. Isolated fibroblasts showed a higher senescence, reduced 
proliferation rates and altered cell morphology, consistent with the death of the patients 
before the age of three (Boissel et al., 2009). This morphological effect might be the 
result of a splicing defect, because it was shown that FTO affects splicing of the 
adipogenic regulatory factor RUNXT1 by specifically targeting m6As around 3’ and 
5’ splice sites. An increase of m6A modifications at these positions upon depletion of FTO 
leads to an elevated level of the splicing regulator SRS2, promoting inclusion of target 
exons (Zhao et al., 2014). 
In contrast to FTO, ALKBH5 is mainly expressed in testes and is connected to 
spermatogenesis in mice (Zheng et al., 2013). Knockdown of ALKBH5 in mice leads to 
abnormal expression of spermatogenesis genes and cell apoptosis in testes. This might 
be due to aberrant mRNA processing because ALKBH5 was shown to localise to nuclear 
speckles and co-localise with RNA processing factors, i.e. phosphorylated SC35.  
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Upon depletion of ALKBH5, SC35 phosphorylation is lost in human cell lines and mRNA 
export is facilitated (Zheng et al., 2013). Beside the function in testes, ALKBH5 was 
shown to be a target of hypoxia induced transcription factor Hif1-α and plays a role in 
regulating pluripotency factors in breast cancer stem cells upon exposure to hypoxia 
(Thalhammer et al., 2011; Zhang et al., 2016). 
 
1.6 Recognition of RNA modifications 
1.6.1 The YTH domain and m6A recognising proteins 
In addition to the identification of METTL3/METTL14 as an m6A methyltransferases 
complex (also termed m6A ‘writers’) and ALKBH5/FTO as m6A ‘erasers’, an exciting 
discovery was the identification of proteins that specifically recognise the m6A 
modification in cellular RNA and thereby can influence the fate of the RNA. These 
proteins are called m6A ‘readers’ (reviewed in Wang and He, 2014). The first proteins 
that were identified as such reader proteins all share a common feature, which is a 
specific protein domain called the YT521-B homology (YTH) domain (Zhang et al., 2010), 
however, more recently, non-YTH domain-containing readers have also been identified 
(see section 1.6.3). 
The YTH domain was first described in the human splicing factor YT521-B and shortly 
after, was defined as a new class of RNA-binding domain that is exclusively present in 
eukaryotes (Hartmann et al., 1999; Imai et al., 1998; Stoilov et al., 2002; Zhang et al., 
2010). In humans, five YTH domain-containing proteins are known (YTHDF1, YTHDF2, 
YTHDF3, YTHDC1, YTHDC2) and for some of these proteins, different functions in RNA 
metabolism have been described (Theler et al., 2014; Wang et al., 2014a; Wang et al., 
2015; Xiao et al., 2016; Xu et al., 2015). A crystal structure of the YTH domain of 
YTHDF2 revealed the recognition mechanism by which the m6A is identified  
(Zhu et al., 2014). The YTH domain of YTHDF2 consists of three α-helices and eight  
β-strands (Figure 4). The six central β-strands (β8- β1- β3- β4- β5- β2) are arranged in an 
open β-barrel-type fold surrounded by the three α-helices, which together constitute the 
hydrophobic core (Li et al., 2014). Residues of the α1 α-helix, β2 β-strand and β4-β5 loop 
form a hydrophobic pocket for m6A binding. The interactions are established by three 
highly conserved tryptophan residues, which build an aromatic cage around the m6A. 
The adenine moiety is sandwiched between two parallel oriented tryptophans, while the 
methyl group is pointed towards the third one. Additional hydrogen interactions select for 
an adenine residue, locking the m6A into place (Li et al., 2014). The area around the 
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m6A-binding pocket is positively charged, resembling an RNA interaction surface  
(Li et al., 2014; Xu et al., 2015). The crystal structures of YTHDC1 and MRB1, which is a 
homologue of the yeast YTH domain-containing protein Pho92 in Zygosaccharomyces 
rouxii, showed similar structural properties (Luo and Tong, 2014; Xu et al., 2014).  
The presence of a YTH domain is, however, not necessarily synonymous with m6A 
recognition. Despite sequence and structural similarities, including a potential 
hydrophobic pocket for accommodating the m6A residue, the yeast protein Mmi1 does 
not bind to the m6A consensus motif (Wang et al., 2016a). It was shown to bind to the 
DSR motif instead, which is specific for meiotic transcripts in yeast. Mmi1 recognizes the 
motif via a long positively charged groove opposite of the potential m6A binding pocket. 
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Figure 4: Crystal structure of the YTH domain. A Crystal structure of the YTH domain of YTHDF2  
(PDB 4RDN, Li et al., 2014) represented in cartoon mode. α-helical secondary structures are coloured in 
green, β-strands are depicted in blue and flexible regions are shown in orange. α-helices are numbered from 
α1 to α5 starting at the N-terminus. The m6A is represented in stick mode and is coloured in red. B Detailed 
view of the hydrophobic m6A-binding pocket of the YTH domain. Important tryptophan residues (orange) 
defining the hydrophobic pocket and the m6A modification (red) are represented as stick models and labelled 
accordingly. Nitrogen atoms of the stick models are coloured in blue. 
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The area surrounding the potential m6A binding pocket is, in contrast to the other YTH 
domains, negatively charged, thus repulsing potential m6A-containing RNAs. 
1.6.2 Functions of YTH domain proteins 
YTHDF2 was the first protein of this family that was shown to bind to the m6A 
modification in vivo using PAR-CLIP, a protein-RNA cross-linking based 
immunoprecipitation followed by deep sequencing of the co-purified RNA  
(Wang et al., 2014a). These data show that YTHDF2 binds to a subset of m6A-containing 
mRNAs, while 59 % of the YTHDF2 binding sites overlap with m6A sites identified by 
m6A-Seq in the same cell line. In accordance with the m6A pattern in mRNAs, YTHDF2 
binds primarily around stop codons and within long exons. Ribosome profiling of 
YTHDF2 target mRNAs upon knockdown of YTHDF2 revealed reduced translation 
efficiency suggesting an increased pool of non-translatable mRNAs and a role for 
YTHDF2 in degradation of aberrant mRNAs. This is in line with the prolonged lifetime of 
YTHDF2 target mRNAs and an increase in m6A/A ratio in total mRNAs and in the 
translatable pool after YTHDF2 depletion (Wang et al., 2014a). The SON mRNA was 
identified as a specific target of YTHDF2 where the C-terminal YTH domain of the protein 
specifically recognises m6A modification in the mRNA, while the N-terminal part of the 
protein is responsible for the localisation of this complex to processing (p)-bodies for 
degradation of the mRNA (Wang et al., 2014a). A second function of YTHDF2 was 
reported under heat stress conditions (Zhou et al., 2016). YTHDF2, which is cytoplasmic 
under normal conditions, re-localises to the nucleus, where it is suggested to interact with 
m6As in the 5’ UTR of specific mRNAs, preventing FTO from demethylation of these 
sites. The increased methylation in the 5’ UTRs is proposed to facilitate cap-independent 
translation of heat shock response genes (Meyer et al., 2015). 
YTHDF1 was the second m6A binding protein that was found to have a regulatory 
function on the mRNA level (Wang et al., 2015). However, in contrast to YTHDF2, 
YTHDF1 is involved in regulating translation efficiency of particular mRNAs.  
Knockdown of YTHDF1 does not alter the overall m6A/A ratio in cells implying that it is 
not involved in RNA turnover. In contrast, knockdown of YTHDF1 leads to reduced 
ribosome occupancy of YTHDF1 target mRNAs and a reduced quantity of these mRNAs 
in the translated pool, suggesting a direct involvement in translation. Consistent with this, 
co-immunoprecipitation experiments also confirmed the interaction of YTHDF1 with 
translation initiation factors (Wang et al., 2015). Furthermore, tethering assays displayed 
a translation promoting effect of the N-terminal domain of YTHDF1, revealing an overall 
protein structure similar to YTHDF2, with an N-terminal protein-interaction domain and a 
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C-terminal YTH domain that mediates interactions with m6A-containing mRNAs  
(Wang et al., 2014a; Wang et al., 2015). The finding that YTHDF1 seems to recognise 
m6As near STOP codons and affects translation initiation by a direct interaction with the 
initiation factor eIF3 that primarily binds to the 5’ end of mRNAs, led to the proposal that 
YTHDF1 takes advantage of the loop structure formed by eIF4G binding to the poly-A-
binding-protein PABP and the initiation factor eIF4E (Wang et al., 2015). Also, YTHDF1 
is suggested to keep the translation initiation complex primed during stress that is 
reducing translation, which then leads to a shorter recovery time after stress  
(Wang et al., 2015). Together, YTHDF2 and YTHDF1 form a tight regulation network for 
m6A modified mRNAs, resulting in short-lived mRNAs with high translation rates, 
enabling rapid adaptation of gene expression in response to changing environmental 
conditions.  
YTHDF3 is the least studied member of the three YTHDF proteins. Along with YTHDF1 
and YTHDF2, it was shown that it binds to viral m6A-containing RNAs of HIV-1  
(Tirumuru et al., 2016). By binding to the viral RNA, the proteins block reverse 
transcription after HIV-1 cell infection. Overexpression of the three YTHDF proteins in 
different HIV-1 infected cells leads to decreased HIV-Gag protein expression, while 
knockdown has the opposite effect. Therefore, the three YTHDF proteins can have an 
influence on HIV-1 at the time of infection of the cell and at the time of virus production 
after integration of the viral RNA into the genome. Since this function of YTHDF3 is 
redundant with YTHDF1 and YTHDF2, it is likely that the main function of the protein in 
the cell remains to be identified.  
For several years YTHDC1, formerly called YT521-B, was known to be involved in pre-
mRNA splicing, however, the mode of regulation remained elusive and direct evidence 
was missing (Hartmann et al., 1999; Imai et al., 1998). Recently, it was shown that 
YTHDC1 functions in alternative splicing by interacting with splicing enhancer-binding SR 
proteins, specifically SRSF3 and SRSF10 that function to promote inclusion and skipping 
of their targeted exons, respectively (Xiao et al., 2016). In vitro experiments confirmed 
interactions between the N-terminal domain of YTHDC1 and the C-terminal domains of 
SRSF3 and SRSF10. However, in vivo YTHDC1 seems to interact mainly with SRSF3 
and knockdown of YTHDC1 abolishes SRSF3 localisation to nuclear speckles and 
decreases its RNA binding. Depletion of YTHDC1 has the opposite effect on SRSF10, 
increasing its RNA-binding ability and promoting its localisation to nuclear speckles.  
The same is true when reducing the global m6A level by knocking down METTL3, 
showing that the m6A binding ability of YTHDC1 is important. Together, this suggest a 
model in which m6A modifications can mark an exon for inclusion by recruiting the 
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YTHDC1-SRSF3 complex, while if the site is not modified, SRSF10 binds instead, 
promoting exon skipping.  
Little is known about the close homologue of YTHDC1, YTHDC2. Reports connect it to 
pancreatic cancer and facilitated hepatitis C virus replication (Fanale et al., 2014; 
Morohashi et al., 2011). Lately, reports suggest that it is involved in cancer metastasis by 
enhancing the translation of hypoxia-inducible-factor-1alpha (HIF-1α) (Tanabe et al., 
2016). Colon-tumour cells injected in mice showed a reduced metastasis rate compared 
to WT cells if YTHDC2 was knocked down and in vitro studies showed less cell mobility. 
This is supposed to be influenced by the increased translation level of HIF-1α. On a 
molecular level, YTHDC2 may be involved by unwinding secondary structures in the 
5’ UTR of HIF-1α, thus enhancing translation initiation (Tanabe et al., 2016).  
1.6.3 Other m6A modification readers 
In addition to YTH domain-containing proteins, several other cellular proteins have 
recently been found to recognise m6A. However, more evidence is needed in some 
cases to prove a direct interaction with the modification. The RNA stabilizing protein HUR 
was detected in RNA affinity assays using short RNA oligonucleotides containing the 
m6A modification as a bait (Dominissini et al., 2012). HUR is known to bind to uridine-
stretches in the 3’ UTR of RNAs, thus its enrichment in m6A pull downs was unexpected 
(Kishore and Stamm, 2006; Lebedeva et al., 2011). Further experiments lead to the 
conclusion that HUR is not recognising the modification itself, but instead is binding in 
close proximity to it. Depending on the presence of the modification, different secondary 
structures could change the accessibility of the HUR binding motif and extend the lifetime 
of the mRNA (reviewed in Wang and He, 2014).  
Stress was shown to increase m6A abundance in 5’ UTRs, which facilitates  
cap-independent translation of particular mRNAs by increasing binding of translation 
initiation factors, without the help of YTH domain reader proteins (Meyer et al., 2015).  
In vitro and in vivo assays showed enhanced interaction of the eukaryotic initiation factor 
eIF3 with such mRNAs, dependent on the presence of modification. It has been 
suggested that this mode of translation initiation could be used during heat shock when 
the levels of m6As in 5’ UTRs are elevated, resulting in increased Hsp70 translation 
(Meyer et al., 2015; Zhou et al., 2015). 
The nuclear protein HNRNPA2B1 is involved in micro (mi)RNA processing and 
alternative splicing. CLIP experiments showed that the binding sites of HNRNPA2B1 on 
cellular RNAs overlap known m6A modification sites and m6A-containing RNA could be 
detected in HNRNPA2B1 immunoprecipitations. 52 out of 53 miRNAs that contain m6A 
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residues are reduced upon HNRNPA2B1 knockdown. These results, combined with the 
interaction of HNRNPA2B1 with the microprocessor protein DGCR8, led to the proposal 
that HNRNPA2B1 functions as a reader of the m6A modification in miRNAs thereby 
effecting miRNA processing (Alarcon et al., 2015). 
Surprisingly, a new study suggests that the m6A writer METTL3 can also act as a  
non-conventional m6A reader (Lin et al., 2016). METTL3 partially relocates to the 
cytoplasm in human cancer cells and seems to be involved in the translation of certain 
oncoproteins for increased cell proliferation, survival and invasion. The other components 
of the methylation complex WTAP and METTL14 are not relocated to the cytoplasm and 
the C-terminal methylation domain of METTL3 is dispensable for translation 
enhancement making it a unique feature of METTL3. The N-terminal domain METTL3 
directly interacts with the initiation factor eIF3 recruiting it to the initiation complex in an 
YTHDF1-independent manner. Overall, translation regulation via the m6A modification is 
a complicated process and it seems that several translation regulation mechanisms act in 
parallel on different mRNA transcripts. 
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1.7 Aims  
RNA modifications are present in many cellular RNAs and can influence the properties 
and functions of the RNAs that carry them in a variety of different ways. However, the 
substrates of many modification enzymes are unknown and often the roles of specific 
modifications remain elusive. Recent findings highlight the N6-methyladenosine (m6A) 
modification as an important regulator of RNA metabolism as it was found to be present 
in mRNAs and was revealed to be reversible. Furthermore, proteins were identified that 
can specifically bind to this modification via a special recognition domain termed the YTH 
domain. A family of five YTH domain-containing proteins have been identified in human 
cells and YTHDF2 was shown to regulate the levels of specific m6A-containing mRNAs 
by targeting them for degradation. At the outset of the project, however, RNA substrates 
of the other YTH domain-containing proteins and their cellular functions were not known. 
The objectives of this study were the further development of computational tools to aid in 
the identification of RNA substrates of proteins involved in introducing or recognising 
RNA modifications and the genome-wide identification RNA interaction sites of the YTH 
domain-containing proteins. 
Therefore, this work aimed to: 
• Adapt a bioinformatic pipeline for the genome-wide mapping of next-generation 
sequencing data derived from cross-linking and analysis of cDNA (CRAC) 
experiments in human cells 
• Identify the RNA targets of YTH domain-containing proteins using the CRAC 
approach 
•  Analyse recognition of the m6A modification by the YTH domains of the different 
proteins 
• Provide insight into the functions and interactions of YTHDC2
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals and enzymes 
Chemicals were obtained from Applichem, Roth and Sigma-Aldrich at molecular biology 
quality or above. Enzymes were generally supplied by ThermoFisher scientific or NEB if 
not stated otherwise. Antibodies were purchased from Jackson ImmunoResearch, Bethyl 
or Sigma-Aldrich. Small interfering (si)RNA was ordered from Qiagen or were 
synthesised at MWG if sequence were available.  
2.1.2 Oligonucleotides 
Table 1 Oligonucleotides used in this study. Restriction sites are underlined; mutated nucleotides are 
lowercase. 
Name Sequence (5’-3’) Application 
TUBG1_Fw CGGCTGAATGACAGGTATCCTA qPCR 
TUBG1_Rv CACCACATCGCTCATCTCGT qPCR 
GAPDH_Fw CAGCCTCAAGATCATCAGCAATG qPCR 
GAPDH_Rv GTCTTCTGGGTGGCAGTGATG qPCR 
YTHDC2_Fw GCCAGAGGCAGCTAGTTTATTG qPCR 
YTHDC2_RV GAGACCAAGGTTTAGATGGAGC qPCR 
YTHDC1_Fw ACCAGGAAGTGGACAGACGA qPCR 
YTHDC1_Rv TTCCTGGGTAAGGGGGCATT qPCR 
YTHDF2_Fw TGTTAAAAAGGAACGTCAAGGTCG qPCR 
YTHDF2_Rv GCAAGTCTGCAATCGTCTCTG qPCR 
YTHDC2seq1_Fw ATTCAAAGATTTCCTGTCACCAA sequencing  
YTHDC2seq2_Fw GCTTCGTACATTGATGGCAGGAGA sequencing 
YTHDC2seq3_Fw AATGGATGCTTGCCTTTCTGATA sequencing 
YTHDC2seq4_Fw CGGTTTGCTGACAGTACACATAGA sequencing 
YTHDC2seq5_Fw AGATCTGACTGAACTTGGGTAT sequencing 
YTHDC2seq6_Fw AAACTCTGAGAATTGGGCTGTCGT sequencing 
YTHDC2_BamHI_Fw ATATGGATCCACCATGTCCAGGCCGAGCAG cloning 
YTHDC2_Nhe_Rv ATATAGCTAGCATCAGTTGTGTTTTTTTCTCCCAAGG cloning 
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DC2_192_BamHI_Fw ATATGGATCCCCAATGTCTTTACCAGTGTTTGAGAAACAGG cloning 
DC2_1287_NheI_Rv ATATAGCTAGCAGGCATGTTTGGTCTTGGCG cloning 
YTHDF1_BamHI_Fw AAAAGGATCCGCCACCATGTCGGCCACCAGCGTGG cloning 
YTHDF1_NheI_Rv AAAAGCTAGCTTGTTTGTTTCGACTCTGCCGTTCC cloning 
YTHDF2_KpnI_Fw AAAAGGTACCGCCACCATGTCGGCCAGCAGCCTCTTG cloning 
YTHDF2_BamHI_Rv AAAAGGATCCTTTCCCACGACCTTGACGTTCC cloning 
YTHDF3_BamHI_Fw AAAAGGATCCGCCACCATGTCAGCCACTAGCGTGGATCAG  cloning 
YTHDF3_NheI_Rv AAAAGCTAGCTTGTTTGTTTCTATTTCTCTCCCTACGC cloning 
YTHDC1_KpnI_Fw AAAAGGTACCGCCACCATGGCGGCTGACAGTCGGG  cloning 
YTHDC1_NheI_Rv AAAAGCTAGCTCTTCTATATCGACCTCTCTCCCC cloning 
DF2_380_BahmHI_Fw ATATGGATCCTCTACTCCTTCAGAACCCCACC cloning 
DF2_579_XmaI_Rv ATATCCCCGGGTTATTTCCCACGACCTTGACG cloning 
DC2_1277_BamHI_Fw ATATGGATCCTCAAAATCTCCTTCGCCAAGACC cloning 
DC2_1430_XmaI_Rv ATATCCCCGGGTCAATCAGTTGTGTTTTTTTCTC cloning 
DC1_344_BamHI_Fw ATATATGGATCCACCAGTAAACTCAAATATGTGCTTC cloning 
DC1_509_XmaI_Rv  ATATATTCCCGGGCTAGTGACGCATTTTATGAATGACCTG cloning 
DC2_W1310A_Fw CTCAACAGAAGGGTATcgcGTCTACAACTCCTAGTAATG 
site directed 
mutagenesis 
DC2_W1310A_Rv CATTACTAGGAGTTGTAGACgcgATACCCTTCTGTTGAG 
site directed 
mutagenesis 
DC2_W1360A_Fw GAAGGGAAAAGAGTCAGGAcgcGGGCTCTGCTGGACTAGGAG 
site directed 
mutagenesis 
DC2_W1360A_Rv CTCCTAGTCCAGCAGAGCCCgcgTCCTGACTCTTTTCCCTTC 
site directed 
mutagenesis 
oligo(dT) TTTTTTTTTTTTTTTTTTTTTTTTVN reverse transcription 
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2.1.3 Plasmids used in this study 
Table 2 Plasmids used in this study. 
ID Name Reference 
pMB-044 A21-H10zzTevpQE80N(3) Markus Bohnsack 
pMB-187 pcDNA5/FRT/TO/FLAG Invitrogen 
pMB-1048 pcDNA5-FRT-TO-YTHDF1-cHisPrcFlag This study 
pMB-1049 pcDNA5-FRT-TO-YTHDF2-cHisPrcFlag This study 
pMB-1050 pcDNA5-FRT-TO-YTHDF3-cHisPrcFlag This study 
pMB-1047 pcDNA5-FRT-TO-YTHDC1-cHisPrcFlag This study 
pMB-1089 pcDNA5-FRT-TO-YTHDC2-cHisPrcFlag This study 
pMB-1098 pcDNA5-FRT-TO-YTHDC2_192-1430-cHisPrcFlag This study 
pMB-1100 pcDNA5-FRT-TO-YTHDC2_1-1287-cHisPrcFlag This study 
pMB-1099 pcDNA5-FRT-TO-YTHDC2_192-1287-cHisPrcFlag This study 
pMB-1222 A21-YTHDF2_380-579 This study 
pMB-1246 A21-YTHDC1_344-509 This study 
pMB-1221 A21-YTHDC2_1277-1430 This study 
pMB-1241 A21-YTHDC2_1277-1430_W1310A This study 
pMB-1242 A21-YTHDC2_1277-1430_W160A This study 
 
2.1.4 siRNAs used in this study 
Table 3 siRNAs used in this study. 
Name Sequence (5’-3’) Company 
siYTHDC2_1 CGAAAUUGUUGGACUGAGA(dTdT) eurofins MWG 
siYTHDC2_2 GAAUUGGGCUGUCGUUAAA(dTdT) eurofins MWG 
siYTHDC2_3 CAUGAAAGGGAUCGAUUUA(dTdT) eurofins MWG 
siNT (control) UCGUAAGUAAGCGCAACCC(dTdT) Ambion 
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2.1.5 Antibodies used in this study 
Table 4 Antibodies used in this study. WB, dilution used in western blotting. IF, dilution used in 
immunofluorescence  
Name Product number Company Fold dilution 
Flag F3165 Sigma-Aldrich 1:10,000 for WB; 1:500 for IF 
Tubulin T6199 Sigma-Aldrich 1:5,000 for WB 
YTHDC2 A303-026A Bethyl  1:10,000 for WB 
XRN1 A300-443A-3 Bethyl 1:10,000 for WB 
Goat-anti-mouse-HRP 115-035-003 Jackson ImmunoResearch 1:10,000 
Goat-anti-rabbit-HRP 111-035-003 Jackson ImmunoResearch 1:10,000 
Goat-anti-mouse-Alexa488 115-545-003 Jackson ImmunoResearch 1:1,000 
 
2.2 Methods 
2.2.1 Molecular cloning 
The plasmids used in this study (see 2.1.3) were created using standard cloning 
techniques. In brief, cDNA was prepared from human cell culture cells (see 2.2.11) and 
the sequence of interest was amplified using sequence specific primers (see 2.1.2) and 
Phusion Polymerase (ThermoFisher scientific) according to manufacturer’s instructions. 
10 % of the reaction was analysed on a 1-2 % DNA agarose gel in 1x TAE (40 mM Tris 
pH 7.6, 20 mM acetate, 1 mM EDTA) to verify the correct size of the product. The rest of 
the reaction was purified using the PCR clean up Kit (Macherey-Nagel). To generate 
compatible ends 1-2 µg of vector or purified PCR product were incubated at 37°C for 2 h 
in a 15 µl reaction volume using restriction enzymes according to the manufacturer’s 
instructions (ThermoFisher scientific). To increase the ligation efficiency and prevent  
re-circularisation, the vector was dephosphorylated for 20 min with 1 U Fast-alkaline 
phosphatase (ThermoFisher scientific). The DNA was separated on a 1-2 % agarose gel 
and gel purified using the Gel purification Kit (Macherey-Nagel). 50 ng of vector and a  
5-fold molar excess of insert were used in a 20 µl ligation reaction using T4 DNA ligase 
(ThermoFisher scientific). The reaction was incubated for 2 h at 22°C or overnight at 
16°C. Chemically competent Top10 cells were transformed with the ligation reaction and 
plated on LB-agar plates containing 100 µg/ml. After incubation at 37°C overnight, 
individual colonies were picked and 4 ml overnight cultures in LB-medium were 
inoculated. The next day plasmid DNA was isolated from the overnight cultures using a 
Mini-Prep plasmid isolation kit (Macherey-Nagel) according to the manufacturer’s 
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instructions. The identity of the clones was verified by restriction digest and Sanger 
sequencing at GATC Biotech. 
2.2.2 Site-directed mutagenesis  
Site directed mutagenesis was used to introduce specific sequence mutations into 
plasmids. Mutagenic PCR primers were designed in such a way that the forward and 
reverse primer were fully complementary with the mutation placed in the middle of both 
primers with at least 15 flanking bases on each side ending with a guanine or cytidine. 
Three 50 µl reactions were set up with 5 ng, 20 ng or 50 ng of template plasmid. In 
addition, the reactions contain 125 ng of each primer, 0.2 mM of dNTP mix, PfuT buffer 
(10 mM Tris pH 8.85, 25 mM KCl, 5 mM (NH4)2SO4, 2 mM MgSO4) and 2 U of 
homemade PfuT polymerase. The thermal cycling program was as follows: denaturation 
at 95°C for 30 sec, then 12-18 cycles of 95°C, 30 sec; 55°C, 1 min; 68°C, 120 sec/kb 
plasmid length. 12 cycles were used for a point mutation, 16 cycles for a triplet change 
and 18 cycles for multiple triplet insertions or deletions. After the PCR, the samples were 
briefly chilled on ice, 1 µl of DpnI was added and the reactions were incubated at 37°C 
for 2 h to fragment the methylated template DNA. Afterwards the three reactions were 
pooled and the DNA was precipitated by adding 0.1 volume of 3 M sodium acetate  
pH 5.2 and 3 volumes of 100 % ethanol, followed by incubation at -20°C for at least 1 h. 
After centrifugation at 20,000 rcf for 20 min at 4°C, the pellet was washed once with 
70 % ethanol and resuspended in 10 µl ddH2O. E. coli Top10 cells were transformed and 
selected on appropriate agar plates. Plasmid DNA was isolated from single colonies as 
described above (2.2.1) and the presence of the mutation was confirmed by sequencing 
at GATC Biotech.  
2.2.3 SDS-PAGE and western blotting 
SDS-polyacrylamide gel electrophorese was performed according to Laemmli (Laemmli, 
1970). Protein samples were pre-incubated with 1x SDS loading dye (60 mM Tris pH 6.8, 
2 % SDS, 10 % glycerol, 0.01 % bromphenol blue, 1.25 % β-mercaptoethanol) and 
heated to 95°C for 5 min. The gels were run on a Biorad system according to the 
manufacturer’s instructions. Subsequently, the gels were either stained using Coomassie 
brilliant blue (0.1% Coomassie brilliant blue G-250, 0.1 % Coomassie brilliant blue R-250, 
10 % acetic acid, 40 % methanol) and destained (10 % acetic acid, 30 % methanol) or 
subjected to western blotting. 
For western blotting, the proteins were transferred onto PVDF or nitrocellulose 
membrane at 100 V for 60 min in blotting buffer (250 mM Tris, 1.92 M glycine, 20 % 
methanol (v/v) using a wet blot system (BioRad). The membrane was then blocked using 
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TBS (50 mM Tris pH 7.6, 150 mM NaCl) supplemented with 5 % milk powder. Incubation 
with the primary antibody was done in 5 % milk in TBS for 3 h at room temperature (RT) 
or overnight at 4°C. After three times 10 min washing with TBS supplemented with 0.1 % 
Triton X-100 (TBS-T) the blots were incubated with the secondary antibody coupled to 
horseradish peroxidase for 1 h at RT. Three additional washing steps with TBS-T were 
performed, the blot was developed using Immobilon™ ECL solution (Millipore) and 
signals were detected by exposure of an x-ray film. 
2.2.4 Cell culture 
HeLa CCL2 or HEK Flp-In™ T-REx™ 293 (Invitrogen) cell lines were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10 % foetal calf serum 
(FCS) and 100 U/ml Penicillin-Streptomycin mix (Gibco). The cells were cultivated at 
37°C, 5 % CO2 in a dark and humid environment. To maintain viability, after washing with 
Phosphate buffered saline (PBS) (Gibco) the cells were detached using Trypsin-EDTA 
(0.25 %) (Gibco) and were seeded onto a new plate every three days in a 1:10 dilution. 
 
2.2.5 Generation of HEK293 stable cell lines 
The Invitrogen Flp-In™ system was used to generate stable cell lines. The gene of 
interest is cloned into the expression vector pcDNA5 vector generating a fusion protein 
with  a C-terminal His6PrecFlag2-tag. Following transfection the construct is integrated at 
a specific location in the genome by a single recombination event utilising the  
Flp recombinase. Expression of the gene of interest is controlled by the CMV promoter 
and is inducible by tetracycline or doxycycline. The introduced hygromycin resistance 
gene is utilised for the selection of positive clones. 
300,000 HEK Flp-In™ T-REx™ 293 cells were seeded into a well of a 6-well plate to be 
50% confluent on the day of transfection. The next day, 0.6 µg pcDNA5 plasmid 
conteining the sequence of the ORF to be expressed was mixed with 1.8 µg pOG44 
plasmid, which enables expression of the Flp recombinase. In a second tube 9 µl  
X-treme Gene HP DNA transfection reagent was mixed with 91 µl Opti-MEM reduced 
serum medium (ThermoFisher scientific) and incubated at RT for 5 min. The two 
reactions were mixed and incubated at RT for additional 15 min. Fresh DMEM media 
without penicillin-streptomycin was applied to the cells, the transfection mixture added in 
a drop wise manner cells were cultivated for two days. The cells were then trypsinised 
and transferred to a 10 cm dish and selection for positive transformats was started by 
addition of 100 µg/ml hygromycin B (Applichem) and 10 µg/ml blasticidin S (Applichem). 
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The cells were washed with PBS and fresh medium with antibiotics was supplied every 
two to three days until single colonies were visible under the light microscope. At this 
stage the cells were trypsinised and resuspended to acquire a mixed population. At 80 % 
density the cells were split onto a new plate and hygromycin B selection was maintained 
during the cultivation of the cells and blasticidin S was added every third split. 
To verify expression of the tagged protein 125,000 cells were seeded into a well of a  
24-well plate and induced with 1 µg\ml doxycycline for 24 h. The medium was removed 
and the cells were washed once with PBS before adding 100 µl of 1x SDS-loading dye. 
10 % of the sample was analysed by SDS-PAGE and Western blotting using specific 
antibodies against the tagged protein. 
2.2.6 Immunofluorescence 
Sterile poly-L-lysine coated coverslips were placed into 24-well plates and cells were 
seeded to be 50 % confluent at the time of fixation. The cells were washed three times 
with PBS before fixation with 4 % paraformaldehyde in PBS at RT for 20 min.  
The coverslips were washed again three times with PBS and the cells were 
permeabilised using 0.1 % Triton X-100 diluted in PBS for 15 min at RT. To stop the 
permeabilisation reaction, four additional PBS washes were performed. Reduction of 
background signal was accomplished by 1 h incubation in blocking solution (10 % FCS, 
0.1 Triton X-100, PBS) at RT. The primary antibody, diluted in blocking solution, was 
then applied to the coverslips for 1-2 h at RT. Excess primary antibody was removed by 
three quick washes with PBS followed by three 10 min washes in PBS. The fluorescently 
labelled secondary antibody was applied to the coverslips in the same way as the 
primary antibody and after incubation for 1-2 h at RT, the same washing steps were 
performed. Finally, the coverslips were dipped in ddH2O and ethanol then dried before 
mounting onto glass slides using 4 µl of Vectrashield mounting medium (Vector 
laboratories). Confocal microscopy was performed on a LSM 510 META (Zeiss). 
2.2.7 Immunoprecipitation 
Immunoprecipitation experiments were conducted using HEK293 cell lines expressing a 
stably integrated His-Prc-2xFlag tagged version of the gene of interest (2.2.5) and αFlag 
M2 magnetic beads (Sigma Aldrich) for precipitation. Tagged protein expression was 
induced at the endogenous protein level with doxycycline. Approximately 1.4∙107 cells 
were harvested using gentle PBS washing to detach the cells from the plate. The cells 
were harvested by centrifugation at 200 rcf for 3 min. The supernatant was aspirated and 
the pellet was snap-frozen in liquid nitrogen and stored at -80°C or kept on ice for 
immediate use. The pellet was resupended in 1 ml lysis buffer (150 mM KCl, 20 mM 
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Hepes pH 8.0. 0.1 mM DTT) and sonicated on ice (20 % amplitude, 0.3 sec pulse, 
0.7 sec off, 3x 16 pulses, 20 sec intervals). After the sonication step, the lysate was 
supplemented with 0.2 % Trition X-100, 10 % glycerol and 1.5 mM MgCl2. Cell debris 
was pelleted by centrifugation at 20,000 rcf, for 10 min, at 4°C. 50 µl of αFlag M2 
magnetic beads were equilibrated by washing three times in ice cold IP buffer (150 mM 
KCl, 20 mM Hepes pH 8.0. 0.1 mM DTT, 0.2 % Trition X-100, 10 % glycerol, 1.5 mM 
MgCl2). After centrifugation the cleared lysate was directly added to the equilibrated 
beads or was subjected to RNA digest. For the RNA digest a 1:1,000 dilution of RNase A 
(4.5 U/µl stock solution) and RNase T1 (1 U/µl stock solution) was added and samples 
were incubated for 15 min at RT before adding to the equilibrated beads. After incubation 
for 2 h at 4°C on a rotating wheel none-specifically bound proteins were removed by 
washing the beads four times with 1 ml ice cold IP buffer. During the last wash the beads 
were transferred to a new tube. The Flag-tagged proteins and any co-precipitated 
proteins were then eluted by adding 50 µl of Flag-peptide solution (250 µg/ml Flag-
peptide, 20 mM HEPES pH 8.0, 150 mM KCl and 1.5 mM MgCl2, 0.05% Triton X-100) 
and incubating the suspension shaking for 30 min at 12°C. The elution step was 
repeated and the two elution fractions were pooled. Precipitation of the proteins was 
facilitated by trichloroacetic acid (TCA) to a final concentration of 20 % and incubation on 
ice for 20 min. Finally, the samples were centrifuged at 20,000 rcf for 20 min at 4°C.  
The supernatants were discarded and the pellets were washed once with ice-cold 
acetone, briefly centrifuged at 20,000 rcf for 10 min at 4°C and air dried for 5 min.  
The pellets were resuspended in 4x NuPage loading dye (Invitrogen) supplemented with 
50 mM DTT and separated on a 4-12 % NuPage Bis-Tris gel system (Invitrogen) with 
MES running buffer (50 mM MES, 50 mM Tris, 1 mM EDTA, 0.1 % SDS) if the samples 
were to be analysed by mas spectrometry. Alternatively, samples were resuspended in 
1x SDS-loading dye and analysed by SDS-PAGE and subsequent western blotting. 
 
2.2.8 Pre-ribosome and sucrose density gradients and polysome profiling 
Sucrose density gradients were performed to separate ribosomal particles according to 
their sedimentation coefficient. 107 cells were harvested using trypsin digestion and 
pelleted. After shock frosting in liquid nitrogen the pellet was stored either at -80°C for 
later use or directly thawed on ice for imminent use. After resuspension of the pellet in 
500 µl lysis buffer (50mM Tris pH 7.5, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT) the cells 
were lysed by sonication (20 % amplitude, 0.3 sec on, 0.7 sec off, 3x 20 pulses, 20 sec 
intervals). Prior to loading on the sucrose gradient the lysate was cleared by 
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centrifugation at 20,000 rcf for 15 min at 4°C. To prepare 10-45 % sucrose gradients, 
10 % sucrose solution (w/v) and 45 % sucrose solution (w/v), both prepared in lysis 
buffer, were layered and mixed using the GradientMaster (Biocomp) “short sucrose  
10-45 %” program with the following settings: 82.0° angle, 19 speed, rotation time 1 min 
25 sec. The prepared gradients were stored at 4°C for 1 h before use. 400 µl of sucrose 
solution was removed from the top of the gradient and was replaced by 400 µl of cleared 
lysate. The gradients were centrifuged at 23,500 rpm, 16 h, 4°C in a Beckman Coulter 
SW40-Ti swinging bucket 6x 14 ml rotor. After centrifugation, 530 µl fractions were taken 
by hand from the top. The RNA content of the fractions was recorded at 254 nm using 
the NanoDrop ND-2000c (ThermoFisher). Proteins in each fraction were precipitated 
using TCA (2.2.7) and analysed by SDS-PAGE and subsequent western blotting (2.2.3). 
2.2.9 RNA interference 
RNA(i) interference was carried out using small interfering (si)RNAs (Table 3) to 
transiently knockdown specific genes. Cells were seeded one day before transfection to 
reach 20-30 % confluence at the time of transfection. For one well of a 6-well plate, 4 µl 
(HeLa) or 5 µl (HEK Flp-In™ T-REx™ 293) of RNAiMax transfection reagent (Invitrogen) 
and 500 µl Opti-MEM reduced serum medium (ThermoFisher scientific) were premixed 
before adding the mixture to 30 nM siRNA (final concentration) and further incubation for 
15 min at RT. The medium on the cells was changed for fresh DMEM without 
penicillin/streptomycin and the transfection mix was added to the cells in a drop-wise 
manner. The next day the medium was exchanged and 72 h or 96 h after siRNA 
transfection the cells were harvested. For a transfection in a 10 cm dish the volumes 
were tripled. 
2.2.10 RNA extraction 
Total RNA from human cells was extracted using TriReagent (Sigma-Aldrich) according 
to manufacturer’s instructions. In brief, the cells were washed once with PBS and for one 
well of a 6-well plate 1 ml of TriReagent was added and incubated at RT for 1 min.  
The lysate was transferred into a tube and 200 µl chloroform were added. After thorough 
mixing, the samples were incubated at RT for 2 min and then centrifuged at 12,000 rcf, 
for 15 min, at 4°C for phase separation. The upper aqueous phase was carefully 
transferred to a fresh tube, 500 µl isopropanol was added to the upper phase and 
samples were incubated for 5 min at RT to precipitate the RNA. After centrifugation at 
20,000 rcf, for 15 min, at 4°C the supernatant was discarded and the RNA pellet was 
washed once with 70 % ethanol. After centrifugation at 20,000 rcf, for 5 min, at 4°C the 
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supernatant was removed and the pellet was air-dried for 5 min then resuspended in 
20 µl diethylpyrocarbonate (DEPC) treated ddH2O.  
2.2.11 Quantitative real time PCR 
Total RNA was reverse transcribed using the Superscript III reverse transcriptase 
(Invitrogen) according to the manufacturer’s instructions to produce cDNA. 2 µg to 5 µg 
total RNA were mixed with 50 µM oligo(dT)	primer (Table 1) or 186 ng random hexamers 
and 1 µl 10 nM dNTPs. ddH2O was added to 13 µl total volume and the sample was 
incubated at 65°C for 5 min. Afterwards the sample was shortly chilled on ice before 
adding 1 µl 100 mM DTT, 4 µl 5x Superscript III reaction buffer and 1 µl Superscript III. 
Reverse transcription was carried out at 55°C for 1 h. Gene specific primers were 
designed using NCBI Primer-BLAST to achieve high specificity. If applicable, exon-exon 
spanning primers were designed to avoid the amplification of DNA contaminations.  
The primers were designed to have a melting temperature between 57°C and 63°C and 
the product length had to be between 80 nt and 150 nt. To test the primers a serial 
dilution of human cDNA was prepared from 1:5 to 1:625 with a dilution factor of 5. 
Samples were analysed using absolute quantification and 2nd derivative max method.  
CT values were plotted against the dilution factor and only primers with an amplification 
efficiency greater than 90 % were used for qPCR (Table 1).	 Quantitative real time 
(q)PCR was carried out using a Light cycler 480 system (Roche) with the supplied Light 
cycler 480 SYBR Green I Master mix (Roche). For a single well 2.5 µl diluted cDNA, 
0.3 µl 10 mM primer mix, 3.3 µl SYBR Green Master mix and 3.9 µl ddH2O were used. 
The following qPCR program was used: 1x (95°C, 5 min); 50x (95°C, 30 sec; 58°C, 
30 sec, 72°C, 30 sec) Each reaction was pipetted in triplicates to account for pipetting 
errors. Two of the triplicates had to be within 0.5 threshold cycles (CT) otherwise the 
reaction was repeated. The experiments were analysed using the Roche Lightcycler 480 
software version 1.5.1.62. CT values were calculated using the 2nd derivative max method 
of the software and relative quantification was conducted using the ΔΔCT method 
(Schmittgen and Livak, 2008). The results were normalised to GAPDH (NG_007073.2), 
COPS6 (NG_046973.1) or TUBG1 (NG_033886.1) to consider different cDNA amounts.	
2.2.12 Agarose-glyoxal gel electrophoresis and northern blotting 
5 µg of total RNA was mixed with glyoxal loading dye (61 % DMSO (v/v), 20 % glyoxal 
(v/v), 5 % glycerol (v/v), 1x BPTE) and incubated at 55°C for 1 h. A 1.2 % agarose gel 
was prepared using ultra pure agarose (Invitrogen). After loading the samples the gel 
was run at 60 V for 16 h in 1x BPTE (10 mM Pipes, 30 mM Bis-Tris, 1 mM EDTA). 
Afterwards the following washing steps were applied to denature the RNA and enable 
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subsequent transfer; 100 mM sodium hydroxide for 20 min, 0.5 M Tris/1.5 M NaCl for 
15 min twice and 6x SSC (900 mM NaCl, 100 mM sodium citrate) for 15 min. The RNA 
was then vacuum blotted onto Hybond N membrane (GE Healthcare) at approximately -
300 psi for 2 h. After blotting the RNA was cross-linked to the membrane with two times 
180 mJ per cm2 256 nm UV light. To check for efficient transfer and visualise abundant 
RNAs, the membrane was stained with methylene blue (0.3 M sodium actetate pH 5.2, 
0.1 % methylene blue (w/v)) The membrane was then incubated in pre-hybridisation 
buffer (SES1; 0.25 M sodium phosphate pH 7.0, 7 % SDS (w/v), 1 mM EDTA) for 30 min 
at 37°C, rotating. Antisense DNA probes were radioactively labelled in a 20 µl reaction 
using 1 µl 10 U/µl T4 Polynucleotide kinase (ThermoFisher scientific), 2 µl 32P-γ-ATP 
(2 µCi, Perkin Elmer), 2 µl 10 mM oligonuclotide, 2 µl 10x PNK buffer, 12.5 µl ddH2O. 
After labelling, the probe was diluted in SES1 and incubate with the membrane overnight 
at 37°C, rotating. The membrane was then washed with 6x SSC for 30 min at 37°C and 
for 30 min with 2x SSC supplemented with 0.1% SDS at 37°C before drying the 
membrane. Radioactive signals were visualised by exposing the membrane to a 
phosphorimager screen (GE Healthcare) and detection using a Typhoon FLA 9500 laser 
scanner (GE Healthcare). If re-probing was necessary, the membrane was stripped by 
incubation with 0.1x SSC supplemented with 0.1 % SDS (w/v) at 70°C for 1 h with 
shaking before blocking and probing as described above. 
2.2.13 Pulse-chase labelling of RNA 
Cells were transfected with siRNAs in 6-well plates as described in section 2.2.9.  
After 72 h the media was replaced by phosphate-free DMEM and cells were grown for a 
further 1 h. 32P-orthophosphate was added to a final concentration of 15 µCi/ml to fresh 
phosphate-free DMEM and the cells were grown in this media for an additional 1 h.  
The labelled media was then removed and the cells were washed with PBS. Normal 
media was added to the cells and they were grown for a further 3 h. Then the medium 
was removed and the cells were washed with PBS. RNA was extracted using TriReagent 
(Sigma-Aldrich) and separated on an agarose-glyoxal gel (2.2.12) at 185 V for 3 h.  
The RNA was capillary blotted onto Hybond N membrane and radioactive signals were 
visualised using a Typhoon FLA 9500 (GE Healthcare).  
2.2.14 Cross-linking and analysis of cDNA (CRAC) 
108 cells of stably transfected HEK293 cell lines for expression of His6-PreScission 
protease site-Flag2 tagged proteins were used per CRAC experiment. Protein expression 
was induced either with 1 µg/µl doxycycline or the optimal concentration to mimic 
endogenous expression for 36 h. 100 µM 4-thiouridine was added to each plate 6 h 
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before cross-linking if photoactivatable-ribonucleoside-enhanced (PAR)-CRAC was 
done. Before cross-linking the media was removed and cells were washed once with 
30 ml of PBS and 8 ml of PBS was added. The cells were irradiated with 3 x 800 mJ/cm2 
at 254 nm (UV-CRAC), or 2 x 180 mJ/cm2 at 365 nm (PAR-CRAC) using a Stratalinker at 
RT. Subsequently, the PBS was removed and 200 µl of TMN150 (50 mM Tris pH 7.8, 
150 mM NaCl, 1.5 mM MgCl2, 0.1 % NP-40 (v/v), 5 mM beta-mercaptoethanol) 
supplemented with complete mini protease inhibitor EDTA free (Roche) was added 
before harvesting of the cells by scraping. The cells were then lysed by sonication  
(40 % amplitude, 0.5 sec pulse, 0.5 sec off, 3 x 15 pulses, 20 sec intervals). The lysate 
was cleared by centrifugation at 20,000 rcf for 15 min at 4°C. The cleared lysate was 
added to 50 µl anti-Flag-magnetic beads (Sigma-Aldrich) that had been pre-equilibrated 
in lysis buffer and the samples were incubated for 3 h rotating at 4°C. The beads were 
then washed twice with 500µl TNM1000 (50 mM Tris pH 7.8, 1 M NaCl, 1.5 mM MgCl2, 
0.1 % NP-40 (v/v), 5 mM beta-mercaptoethanol) and three times with TMN150. The resin 
was transferred to a new tube during the last washing step. The bound protein was 
eluted by adding 200 µl of TMN150 supplemented with 0.2 µg/µl Flag peptide (Sigma-
Aldrich) and incubation overnight rotating at 4°C. The eluate was transferred to a fresh 
tube, the volume was adjusted to 600 µl with TMN150 and the sample was subjected to 
RNase treatment. 0.1 U RNace-IT was added and the samples were incubated for 
30 sec at 37°C. The reaction was stopped by transferring the sample to a 1.5 ml reaction 
tube containing 0.4 g guanidine hydrochloride, 45 µl 3 M NaCl and 3 µl 2.5 M imidazole 
pH 8. For the denaturing binding step, the samples were incubated with 50 µl of Ni-NTA 
resin (Qiagen) for 2 h rotating at 4°C that had been pre-equilibrated in wash buffer I 
(50 mM Tris pH 7.8, 300 mM NaCl, 10 mM imidazole pH 8, 6 M Guanidine hydrochloride, 
0.1 % NP-40 (v/v), 5 mM beta-mercaptoethanol). The beads were washed twice with 
750 µl wash buffer I and three times with PNK buffer (50 mM Tris pH. 7.8, 10 mM MgCl2, 
0.5 % NP-40 (v/v), 5 mM beta-mercaptoethanol). With the last wash the beads were 
transferred to Mobicol spin columns (Bio-Rad) and incubated with 8 U TSAP (Promega), 
60 U of RNasin (Promega) in PNK buffer for 30 min at 37°C to dephosphorylate the RNA. 
The beads were washed once with wash buffer I to stop the reaction and three times with 
PNK buffer before ligation of the Illumina RA3 3’ adapter to the 3’ end of the RNA.  
The reaction was carried out in PNK buffer with 1 µM  RA3 3’ adapter, 800 U T4 RNA 
ligase 2 deletion mutant (Epicentre), 60 U RNasin (Promega), 10 % PEG8000 (Sigma-
Aldrich) overnight at 16°C. The beads were washed once with wash buffer I to stop the 
reaction and three times with PNK buffer before radioactive labelling of the 5’ end of the 
RNA. A mix of 80 U T4 PNK (NEB), 60 U of RNasin (Promega) in PNK buffer was added 
first before the addition of 32P-γ-ATP and incubation for 40 min at 37°C. 1.25 µM Li-ATP 
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(Roche) was added and the samples were incubated for an additional 20 min.  
The samples were washed once with wash buffer I to stop the reaction and three times 
with PNK buffer before ligation of the RA5 (N5) 5’ adapter to the 5’ end of the RNA.  
The reaction was carried out in PNK buffer with 40 U T4 single-strand RNA ligase I 
(NEB), 1.25 µM RA5 (N5) 5’ adapter, 1 mM ATP (Roche) overnight at 16°C. After the 
ligation reaction the samples were washed three times with 400 µl of wash buffer I and 
seven times with wash buffer II (50 mM Tris pH 7.8, 50 mM NaCl, 10 mM Imidazol pH 8, 
0.1 % NP-40 (v/v), 5 mM beta-mercaptoethanol). The RNA-protein complexes were 
eluted twice with 200 µl Elution buffer (50 mM Tris pH 7.8, 50 mM NaCl, 150 mM 
imidazole, 0.1 % NP-40 (v/v), 5 mM beta-mercaptoethanol). The samples were subjected 
to TCA precipitation before separation in a 4-12 % NuPAGE gel as described in section 
2.2.7. The proteins were transferred onto Hybond C membrane (Amersham) in transfer 
buffer (25 mM Bicine, 25 mM Bis-Tris, 1 mM EDTA, 20 % methanol) and radioactive 
signals were detected by exposure of the membrane to an x-ray film for 1-16 h. 
Membrane segments corresponding to the radioactive signals were excised and the RNA 
was eluted from the membrane by protein digestion with 100 µg Proteinase K, PCR 
grade (Roche) in 400 µl wash buffer II supplemented with 1 % SDS and 5 mM EDTA 
overnight shaking at 55°C. 50 µl 3 M sodium acetic acid pH 5.2 and 500 µl 
phenol:chloroform:isoamylalcohol (25:24:1) were added and centrifuged at 20,000 rcf for 
5 min at RT. The upper phase was transferred to a new tube, 20 µg glycogen was added 
and the RNA was precipitated with 3 vol. of 100 % ethanol overnight at -20°C. The RNA 
is precipitated at 20,000 rcf for 30 min at 4°C and the pellet was washed with 70°C 
ethanol once. The RNA pellet was directly resuspended in the following mix: 10 µL 
ddH2O, 1 µl RTP Primer (10 µM), 2 µl dNTP mix (5 mM, Roche). Reverse transcription 
was carried out using the Superscript III kit (Invitrogen). After inactivation if the reverse 
transcriptase by incubation at 65°C for 15 min, 1 µl of the 20 µl reaction was used for the 
following PCR reaction: 1x LA Tag buffer+MgCl2, 0.2 µM RPI (Illumina forward index 
primer), 0.2 µl RP1 (Illumina general reverse primer), 0.125 mM dNTPs, 2.5 U  
La TakaRa Taq (Clontech). (1x 95°C, 2 min; (40x 98°C, 30 sec.; 60°C, 40 sec; 68°C, 
40 sec); 72°C, 5 min). The PCR products were extracted using 
phenol:chloroform:isoamylalcohol as described above and were precipitated by the 
addition of sodium acetate to a final concentration of 0.3 M and 3 volumes of 100 % 
ethanol then incubation at -20°C overnight. After centrifugation at 20,000 rcf for 20 min at 
4°C, the pellet was washed with 70 % ethanol, dried and resuspended in 2x gel loading 
dye (Qiagen). The PCR product was separated on a 3 % Metaphore agarose gel (Lonza) 
in TBE (89 mM Tris, 89 mM boric acid, 2 mM EDTA) and gel purified using the Qiagen 
MINI elute Kit and RNA-binding columns (Qiagen). Afterwards, the DNA concentration 
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was quantified using the Qubit quantification system (Invitrogen) and the library was sent 
for Illumina deep sequencing.  
2.2.15 Genome-wide mapping of deep sequencing data 
The data received from Illumina deep sequencing were mapped onto the human genome 
version GRCh 37.75 from ensembl (grch73.ensembl.org). In addition one human 
ribosome repeating unit (NCBI accession number U13369.1) and one 5S rRNA 
sequence were added as additional chromosomes. The sequences of the mature rRNAs 
are based on the rRNA sequences shown in the structure of the human 80S ribosome 
(PDB 4V6X; (Anger et al., 2013). Existing 5S sequences similar to the introduced 
sequence were masked with ”N” to get a specific mapping onto the introduced 5S 
sequence. A modified version of the ensembl GTF annotation file was used. Wrongly 
categorised genes were corrected by hand and the tRNA annotation based on 
tRNAscan-SE from Ensembl and the annotation of the introduced rDNA sequences were 
added.  
The sequences obtained from Illumina were 50 bp single read sequences comprised of 
an introduced random barcode NNNNNAGC at the 5’ end to distinguish PCR artefacts 
from the accumulation of independent sequences, the actual sequence and the 3’ linker 
in the case of short reads. Thus, several quality-processing steps have to be made 
before the read can be mapped onto the genome. Firstly, the introduced barcode is 
removed using pyBarcodeFilter from the pyCRAC utility (Webb, 2014). Afterwards the 
read is quality based trimmed, a potential 3’ linker sequence is removed and reads 
shorter than 21 nucleotides are discarded using Flexbar 2.7 with the following settings:  
-q TAIL –qf i1.8 -qt 13 –as TGGAATTCTCGGGTGCCAAGG -ao 2 -u 0 -m 21 -ae RIGHT. 
Duplicated sequences are removed using “pyFastqDuplicateRemover” script from the 
pyCRAC utility and the remaining sequences are mapped onto the genome. If PAR-
CRAC was applied the sequences are mapped with Bowtie 1.1.2 with one mismatch 
allowed and only the best alignments with one T to C conversion are filtered by self-
written python 2.7 scripts and are considered for further analysis. If UV-CRAC was 
applied the sequences are mapped with Bowtie2 2.2.6 using the following settings:  
-D 20 -R 3 -N 1 -L 20 -i S,1,0.50 --rdg 0,11 --mp 10,6 --ignore-quals. Further analysis and 
normalization of the data were done making use of self-written python 2.7 scripts and 
scripts from the pyCRAC utility including “pyReadCounters”, “pyPileup” and 
“pyReadAligner” scripts.  
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For visualization the data were imported into MochiView 1.46 
(www.johnsonlab.ucsf.edu/mochi/) and hits on the rRNA were mapped onto the 2D 
(Petrov et al., 2014) and 3D structure (PDB 4V6X, Anger et al., 2013) of the mature 
human ribosome using self-written python 2.7 scripts and in addition the 3D protein 
viewer pymol (www.pymol.org) for the 3D structure.  
2.2.16 Recombinant expression of proteins in E. coli 
For recombinant expression of proteins in E. coli BL21 codon plus cells (Agilent) the pQE 
derived A21 vector was used, which introduces a N-terminal His10-ZZ-TEV-tag to the 
protein. The main culture was inoculated from an overnight culture and grown to an 
OD600 of 0.5 at 37°C before switching to 16°C and induction with 0.3 mM of IPTG 
overnight. The cells were harvested by centrifugation at 6,000 rcf for 15 min at 4°C.  
They were washed once with PBS before the pellet was snap-frozen in liquid nitrogen 
and stored at -20°C. 
2.2.17 Purification of His-tagged proteins 
A pellet equivalent to a 1 L culture was resuspended in 20 ml lysis buffer (30 mM Tris pH 
7.4, 150 mM NaCl, 1 mM MgCl2, 1 mM PMSF, 10 % glycerol) and the cells were lysed 
using sonication (45 % amplitude, 0.7 sec on, 0.3 sec off, 4x 30 pulses with 30 sec pause 
in between). The lysate was cleared by centrifugation at 25,000 rcf for 30 min at 4°C. 
1 ml of cOmplete His-Tag purification resin (Roche) was pre-equilibrated with 10 ml of 
lysis buffer and the lysate was added three times for binding using the gravity flow 
technique. The resin was then washed two times with 10 ml wash buffer (30 mM Tris pH 
7.4, 300mM NaCl, 15 mM Imidazole pH 8, 1 mM MgCl2, 10 % glycerol) and finally the 
bound protein was eluted with 8 ml elution buffer (30 mM Tris pH 7.4, 150mM NaCl, 
500 mM Imidazole pH 8, 1mM MgCl2, 10% glycerol) and collected in 1 ml fractions. 1µl of 
each fraction was spotted onto a nitrocellulose membrane (Amersham), which was then 
stained with 0.1 % amidoblack in 50 % ethanol. Fractions containing protein were pooled 
and dialysed against 1 L dialysis buffer (30 mM Tris pH 7, 120 mM NaCl, 2 mM MgCl2, 
20 % glycerol) at 4°C overnight using Spectrum dialysis tubing that had been briefly 
boiled in 5 mM EDTA before use. After dialysis, the protein concentration was measured 
using the Pierce Coomassie plus Bradford assay kit (ThermoFisher scientific) and the 
protein was aliquoted, snap-frozen in liquid nitrogen and stored at -80°C.  
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2.2.18 Anisotropy 
For anisotropy measurements, proteins were first dialysed against anisotropy buffer 
(30 mM Tris pH 7.5, 120 mM NaCl) overnight. Increasing concentrations of protein were 
incubated with 20 nM of fluorescein labelled RNA (Table 1) in anisotropy buffer for 5 min 
at RT. The samples were then transferred to a Quartz SUPRASIL® 10x2 mm High 
Precision Cell cuvette (Hellma Analytics) for measurement. Anisotropy measurements 
were performed on a FluoroMax-4 spectrofluorometer (Horriba Scientific) with the 
FluorEssenceV3.5 software at 25°C. The excitation and emission wavelengths were set 
to 470 nm 517 nm, respectively. Excitation slit width was set to 5 nm and emission slit 
width was set to 10 nm. The integration time was 1 sec, the maximal trials per sample 
were set to 6 and the target standard error was 2 %. The data were fitted with formula 1 
and dissociation constants were calculated using the Origin 8.2 software. 
 
1 𝑟 = 𝑟! + ∆!!"#!"# !"! ⋅ !"#$%&' !"!! !"# !"!!!!! − !"#$%&' !"!! !"# !"!!!!! ! − 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 !"! 𝑅𝑁𝐴 !"!  
r0, anisotropy of unbound RNA; rmax, amplitude; [protein]tot, total protein concentration;  
[RNA]tot, total RNA concentration 
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3 Results 
3.1 Bioinformatic analysis of high throughput next-generation 
sequencing data 
RNA binding proteins are a major part of the proteasome of the cell. For characterisation 
of these proteins, it is essential to identify their RNA interaction partners. Therefore, 
cross-linking methods have been established that allow the purification of RNA-protein 
complexes with subsequent next-generation sequencing of the RNA. The first method 
that was established was called CLIP for cross-linking and immunoprecipitation  
(Darnell, 2012). Therein, UV light is used to establish covalent bonds between proteins 
and the RNAs they contact, and the resulting RNA-protein complex is purified via an 
antibody targeting the endogenous protein. However, this relies on the availability of 
highly specific antibodies for purification and the one step purification might lead to 
contaminating RNA that is not cross-linked to the protein of interest. To overcome these 
caveats, new CLIP-based methods were developed such as the cross-linking and 
analysis of cDNA (CRAC) method, which was first established in yeast (Bohnsack et al., 
2009; Granneman et al., 2009). Briefly, CRAC uses a bi-partite terminal-tag, which allows 
a two-step purification of RNA-protein complexes with a specific first elution step utilising 
a protease cleavage site in between the tags (Figure 5A). After the first elution the RNA 
is trimmed to generate a footprint of the protein interaction site on the RNA.  
The remaining His-tag is then used for a second purification under denaturing conditions 
to remove all non-covalently cross-linked RNAs and non-specifically bound proteins. 
During this step, the RNA is radioactively-labelled and sequencing adapters are ligated to 
the 3’ and 5’ ends. Finally, the RNA-protein complexes are eluted, separated by PAGE 
and transferred to a membrane. The radioactively-labelled RNA-protein complex is 
detected by autoradiography, excised from the membrane and the RNA is eluted by 
digestion of the protein. The cDNA library is generated by reverse transcription of the 
RNA and amplification by PCR and is then sent for Illumina next-generation sequencing.  
Two alternative cross-linking approaches can be employed resulting in two different 
protocols called UV-CRAC and photoactivatable-ribonucleoside-enhanced (PAR)-CRAC. 
The first one developed was RNA cross-linking with high energy UV light at 254 nm, 
which can also result in unspecific protein-DNA cross-links. To address this issue, PAR-
CRAC uses the uridine analogue 4-Thiouridine. This is supplemented to the growth 
medium several hours before cross-linking to allow incorporation into nascent RNA. 
Afterwards, lower energy UV light at 365 nm is used, which specifically introduces
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Figure 5: Cross-linking and analysis of cDNA (CRAC). A Schematic overview of the CRAC protocol. Cells 
expressing the protein of interest fused to a FLAG (His6-PreScission protease site-FLAG2)-tag are grown in 
the presence of 4-thiouridine (4thioU) and then cross-linked using light at 365 nm (PAR-CRAC) or are 
directly cross-linked using UV light at 254 nm (UV-CRAC). After a first native purification step of the cross-
linked RNA-protein complexes using αFlag antibodies attached to magnetic beads, the complex is eluted 
and the RNA is trimmed to the binding site of the protein. A second denaturing purification is then carried out 
and “on-bead” linker ligation for library preparation is performed. The protein is digested and purified RNA is 
reverse transcribed, amplified by PCR and sequenced by Illumina next-generation sequencing. 
Abbreviations: 4thioU, 4-thiouridine; F, Flag2-tag; H, His6-tag; PAR, photoactivatable-ribonucleoside-
enhanced. Modified from Haag et al., accepted manuscript. B Schematic overview of the bioinformatic 
pipeline used for CRAC data analysis. The sequence reads from Illumina next-generation sequencing are 
first processed, ensuring that only high quality reads are mapped. Barcodes used for the detection of PCR 
artefacts over representing certain sequences are removed and the sequences are collapsed afterwards. 
The reads are aligned to a modified version of the human genome and, in the case of PAR-CRAC, only 
reads with specific T to C mutations are further analysed. Sense-aligned reads for each gene are summed 
and the numbers are normalised to the total number of sense-aligned reads. The final analysis includes an 
overview of the hit distribution on different types of RNA and prepares the data for visualisation in common 
genome viewers using self-written python scripts. 
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covalent bonds between the thio-group and amino acid side-chains, thereby reducing 
background compared to the UV254 cross-linking approach (Hafner et al., 2011).  
Analysis of the sequencing data can only be achieved using bioinformatical methods, 
because it consists of millions of reads that need to be quality controlled and processed. 
Therefore, an in-house pipeline was developed for the analysis of human UV-CRAC and 
PAR-CRAC data, based on the pyCRAC suite developed for yeast (Webb et al., 2014). 
In general, the pipeline is divided into three major parts: read preparation for the 
alignment, genome-wide read alignment and analysis of the alignment (Figure 5B).  
First, artificial sequences that were added during cDNA library preparation need to be 
removed. The library preparation includes a PCR step, for which sequences 
complementary to the 5’ and 3’ primers are ligated to the RNA. If short RNA sequences 
are amplified, this can lead to sequencing of the 3’ adapter, which then needs to be 
removed before mapping to the genome. Also, a random barcode is added to detect 
overrepresented sequences that were artificially amplified during the PCR step and this 
also needs to be removed. Second, the quality of the sequence read needs to be 
checked before mapping. Illumina sequencing is based on monitoring the incorporation 
of fluorescently labelled nucleotides during DNA synthesis and although this process has 
high accuracy, sometimes bases cannot be identified. Therefore, it is necessary for all 
reads to undergo quality control before they can be mapped. The program Flexbar was 
chosen for this step in the pipeline because it is fast and versatile, and it can remove 
trailing adapter sequences and low quality reads in one step (Dodt et al., 2012). 
Furthermore, Flexbar was set to discard sequence reads that are shorter than 21 nt, 
because short reads increase the possibility of false mapping (i.e. short reads can be 
mapped to multiple places in the genome meaning that their origin cannot be 
unambiguously determined). In the same part of the pipeline, the random barcode is 
removed and reads containing the identical barcodes together with identical sequences 
are consolidated by the “pyBarcodeRemover” and the “pyFastDuplicateRemover” scripts 
from the pyCRAC suite (Webb et al., 2014), so that only unique reads are left.  
The remaining reads can then be aligned to the human genome. For this, an altered 
version of the human genome GRCh 37.75 was generated as a template for the 
alignment. The human ribosomal DNA complete repeating unit (NCBI accession number 
U13369.1) and the 5S rDNA sequence were added as additional chromosomes 
containing the rDNA sequences of the mature rRNAs published in the 3D structure of the 
ribosome (PDB 4V6X; Anger, 2013). Additional copies of the 5S rDNA sequence were 
also masked by ‘N’ in the genome to avoid mapping of sequence reads to multiple 
locations within the genome. Also, a modified version of the ensembl annotation of the 
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genome was generated as the published version contains several incorrectly categorised 
genes (e.g. long non-coding RNAs as mRNAs and snoRNAs as snRNAs). Such genes 
were manually assigned to the correct category and the genome annotation was 
simplified by disregarding the 5’ and 3’ UTR annotation of protein coding genes. 
Various alignment programs can be used for the alignment of the reads to the genome, 
e.g. Bowtie, Bowtie2, novoalign, etc. and different programmes were used depending on 
the cross-linking method. UV-CRAC often induces mutations and microdeletions during 
reverse transcription at the nucleotides that have been cross-linked to amino acids, so 
Bowtie2 was used because it allows mutations as well as gaps in the read alignments 
(Langmead and Salzberg, 2012). Bowtie2 is a versatile program, since penalties can be 
individually set for mutations, the number of gaps in the alignment and the length of the 
gaps. The threshold score, which determines whether an alignment is considered valid or 
not, can also be adjusted as a function of the read length. The standard pipeline settings 
were chosen to allow one mismatch or one gap for short reads below 32 nucleotides, 
however, only the best alignment is reported in the output file. In contrast to UV-CRAC, 
due to the incorporation of 4-thiouridine into cellular RNAs, PAR-CRAC introduces 
specific T to C mutations at the cross-linking site, but no deletions. In this case, the 
Bowtie alignment programme was used, because it has more stringed mapping criteria, 
independent of the read length (Langmead et al., 2009). It is an ultrafast short read 
aligner, which can only detect full alignments containing mutations but no gaps. The 
maximal number of allowed mutations was set to one, allowing only the mutation 
introduced by the cross-link. Bowtie, as Bowtie2, only reports the single best alignment 
and cannot distinguish between different mutations, thus, python scripts were written to 
select for alignments containing T to C mutations for further analysis. The next step in the 
pipeline is to check whether alignments overlap with annotated regions of the genome. 
For this task, the “pyReadCounters” script of the pyCRAC suite was integrated into the 
pipeline. It counts the number of alignments for each annotated genomic feature, which 
are summarised in eleven different RNA categories (tRNA, mRNA, rRNA, micro (mi)RNA 
precursors, mitochondrial (mito)RNA, long non-coding (lnc)RNA, small nucleolar 
(sno)RNA, small nuclear (sn)RNA, pseudogenes and miscellaneous (misc)RNA). The 
data mapped to tRNA genes are then further processed by self-made python scripts so 
that reads aligned with genes encoding for the same type of tRNA, are summed up for 
simplification. Finally, results are reordered and formatted as excel tables using self-
written scripts and the data are normalised to the total number of mapped sense-reads to 
enable comparison of different samples and sequencing runs. 
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3.1.1 Verification of the pipeline  
The pipeline was initially tested with data from UV cross-linking of the helicase DDX21 
that had previously been studied (Sloan et al., 2015). The pipeline was then applied to 
NSUN6 and NSUN3 CRAC data generated by Dr. Sara Haag. When cross-linking these 
RNA methyltransferases to generate data for these analyses, HEK293 cell lines 
expressing genomically integrated version of NSUN6 or NSUN3 with a His6-PreScission 
protease site-Flag2 (FLAG)-tag from a tetracycline promoter had been subjected to UV-
CRAC. Mapping of the obtained Illumina sequencing data using the developed 
bioinformatic pipeline showed an over-representation of tRNAs for the NSUN6 sample 
compared to cells only expressing the FLAG-tag (FLAG, Figure 6A). Closer analysis of 
the reads aligning to tRNA genes showed that tRNAs for threonine, cysteine and arginine 
codons were highly enriched compared to the FLAG control (Figure 6B). Having 
identified tRNAThr and tRNACys as putative RNA substrates of NSUN6, the results of the 
bioinformatic analysis of the CRAC data were then confirmed by analysing RNAs cross-
linked to NSUN6 using Northern blotting (performed by Dr. Haag) and this confirmed that 
tRNAThr and tRNACys are indeed bound by NSUN6 in vivo, thereby verifying the output of 
the new pipeline (Haag et al., 2015b). 
In contrast, analysis of the NSUN3 CRAC data revealed an over-representation of reads 
aligning to the mitochondrial genome, especially mitochondrial tRNAs (Figure 6C), which 
is consistent with the mitochondrial localisation of the protein (Haag et al., 2016). Closer 
analysis of the data showed that among the mitochondrial tRNAs, the mitochondrial 
tRNAMet (mt-TM, Figure 6D) was highly enriched, suggesting mt-tRNAMet as a target of 
NSUN3. As for NSUN6, further in vitro and in vivo experiments (performed by Dr. Haag) 
confirmed the interaction of NSUN3 with mt-tRNAMet and in this case, showed that 
NSUN3 specifically methylates C34 at the wobble position (Haag et al., 2016).  
The finding that the RNA substrates of two proteins that were identified using the human 
CRAC analysis pipeline could be confirmed by biochemical experiments in vivo and in 
vitro shows that the different modules of the pipeline are working correctly together and 
the parameters for alignment and quality control are chosen properly. This therefore 
validates the pipeline as a tool for the mapping of next generation sequencing data 
obtained during CRAC experiments onto the human genome to identify RNA substrates 
of proteins of interest. 
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Figure 6: Genome-wide mapping of NSUN3 and NSUN6 CRAC data. A HEK293 cells expressing 
NSUN6-FLAG or the FLAG-tag alone were UV cross-linked. The RNA-protein complexes were affinity 
purified and the RNA was trimmed, radioactively labelled and ligated to linkers. RNA-protein complexes were 
separated by NuPAGE, transferred to a nitrocellulose membrane and the RNA was isolated from the bound 
RNA-protein complexes by protelytic digest with Proteinase K. The RNA was converted to cDNA for 
sequencing library production and Illumina next-generation sequencing. The pie charts represent different 
(legend continued on next page) 
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RNA classes and the relative distribution of sequencing reads that was obtained after mapping of the reads 
to the human genome. Abbreviations: mRNA, messenger RNA; tRNA, transfer RNA; snRNA, small nuclear 
RNA; snoRNA, small nucleolar RNA; rRNA, ribosomal RNA; mitoRNA, mitochondrial-encoded RNA; 
miscRNA, miscellaneous RNA; miRNA, microRNA; lncRNA, long non-coding RNA. B Relative distribution of 
tRNA sequences obtained from NSUN6-FLAG or FLAG CRAC experiments described in A. Only tRNA 
genes above 3 % are labelled. C HEK293 cells expressing NSUN3-FLAG or FLAG-tag alone were treated 
and analysed as described in A. The bar graphs below the pie charts represent the read distribution of 
mitochondrial (mt)-tRNA, mt-rRNA and mt-mRNA sequence reads among reads mapped to the mitochondrial 
genome. D Relative distribution of mt-tRNA sequences from NSUN3-FLAG or FLAG CRAC experiments 
described in C. Only mt-tRNA genes above 3 % are labelled. The experiments were performed by Dr. Sara 
Haag (Haag et al., 2016; Haag et al., 2015b). 
 
3.2 Identification of RNA interactions of the YTH domain-containing 
proteins 
Having established a bioinformatic pipeline for the mapping of CRAC data onto the 
human genome and verified that this could be used to identify RNA substrates of RNA 
modifying enzymes, we next applied this approach to identify the RNA interaction 
partners of other RNA-binding domain-containing proteins. A family of proteins that has 
raised great interest recently are the YTH domain-containing proteins. The YTH domain 
was suggested to be an RNA binding domain that can specifically recognise the N6-
methyladenosine (m6A) modification. Five YTH domain-containing proteins (YTHDF1, 
YTHDF2, YTHDF3, YTHDC1, YTHDC2) have been identified in humans so far. 
Interestingly, PAR-CLIP analysis of YTHDF2 enabled detection of YTHDF2-associated 
mRNAs leading to the identification of a role for this protein in regulating the decay of 
specific m6A-containing mRNAs (Wang et al., 2014a). This shows that the identification 
of interaction targets is crucial and therefore, CRAC was applied to identify RNA 
interaction partners, which can provide insights into the function of the other YTH 
domain-containing proteins. To perform the CRAC analysis, HEK293 stable cell lines 
where the individual YTH domain-containing proteins could be inducibly expressed with a 
C-terminal FLAG-tag first had to be generated and protein expression verified.  
For this, the coding sequences of the YTH domain-containing proteins, YTHDF1, 
YTHDF2, YTHDF3, YTHDC1 and YTHDC2 were cloned into a pcDNA5 vector encoding 
a C-terminal FLAG-tag. HEK293 T-Rex Flp-In cells were transfected with the constructs 
to generate stable cell lines. The cloned coding sequence is genomically integrated at a 
defined locus in the genome to ensure that no random alterations of the genome can 
occur and transfected cells are selected using antibiotics. To check proper integration of 
the coding sequence of interest, the generated stable cell lines were grown in the 
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presence (induced) or absence (non-induced) of doxycycline for 24 h. Whole cell lysates 
were prepared and separated by SDS-PAGE followed by western blotting (Figure 7). 
FLAG-tagged proteins were detected using an αFlag antibody. For each of the proteins, 
a signal at the expected size was detected for all samples grown in the presence of 
doxycycline, confirming expression of tagged forms of the correct proteins. No signal 
could be detected for non-induced cells, showing that the expression was inducible. 
Tubulin was used as a loading control to display equal loading of the associated 
samples. 
After confirming correct expression of the YTH domain-containing proteins, the cell lines 
were further analysed by immunofluorescence microscopy (IF) to ensure correct 
localisation of the proteins, if known, as well as normal appearance of the cells (Figure 
8). Protein expression was induced for 24 h before fixation of the cells for IF. An αFlag 
antibody was used for the detection of the FLAG-tagged version of the protein and 
nuclear material was visualised by DAPI staining. This shows an exclusively cytoplasmic 
localisation for YTHDF2-FLAG and nuclear localisation for YTHDC1-FLAG, which is in 
line with the localisations reported for the endogenous proteins and with their proposed 
function in mRNA decay and pre-mRNA splicing respectively (Hartmann et al., 1999; 
Wang et al., 2014a). In keeping with their close homology to YTHDF2, YTHDF1-FLAG 
and YTHDF3-FLAG display cytoplasmic localisation similar to YTHDF2-FLAG. 
Interestingly, YTHDC2-FLAG shows localisation to two compartments, a dominant 
cytoplasmic signal and minor nuclear signal.  
Figure 7: Generation of stable HEK293 cell lines expressing YTH 
domain-containing proteins. Whole cell lysate from HEK293 cell lines 
expressing FLAG-tag versions of the indicated proteins was prepared, 
separated by SDS-PAGE and subjected to western blotting. The cells were 
induced (+) for 24 h with doxycycline (Dox) or untreated (-). The FLAG-
tagged proteins were detected using an αFlag antibody. Tubulin was used 
as a loading control and detected with an αTubulin antibody. 
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Figure 8: Localisation of YTH domain-containing proteins. Stable cell lines expressing FLAG-tagged 
versions of the indicated proteins were subjected to immunofluorescence microscopy after 24 h of induction 
of protein expression. An αFlag antibody was used to detect the FLAG-tagged proteins. DAPI staining 
indicates the position of the cell nucleus. The scale bar represents 10 µm. 
 
Having established inducible stable cell lines for the expression of FLAG-tagged versions 
of all five YTH domain-containing proteins, CRAC experiments were performed with 
these cell lines to obtain an unbiased, genome-wide overview of RNA interaction 
partners of the YTH domain-containing proteins. For the PAR-CRAC experiments, 
YTHDF1-FLAG, YTHDF2-FLAG, YTHDF3-FLAG, YTHDC2-FLAG and YTHDC2-FLAG 
cell lines were induced for 36 h to express the FLAG-tagged version of the protein. Cells 
expressing the FLAG-tag alone were used as a negative control. After purification of 
protein-RNA complexes they were then separated by SDS-PAGE, transferred to a 
membrane and radioactive signals of the RNA were detected by autoradiography (Figure 
9). The autoradiogram revealed signals of radioactively-labelled RNA at the expected 
size of the RNA-protein complex in all YTH domain-containing protein samples, 
confirming efficient cross-linking of the tagged proteins to cellular RNAs. As expected, no 
signal was detected in the negative control representing cells only expressing the FLAG-
tag (Figure 9). After excision of the regions of the membrane containing the radioactive 
signals and cDNA library preparation, the library was send for Illumina next-generation 
sequencing. The resulting data were then processed with the established in-house 
human CRAC pipeline.  
Results 
 50 
The overall distribution of the alignments to the different RNA categories was analysed 
first (Figure 10). Compared to the FLAG control, YTHDF1, YTHDF2, YTHDF3 and 
YTHDC1 show an increased number of mRNA alignments (Figure 10A-D, F).  
For YTHDF1, the proportion of the total reads that aligned to mRNA genes increased 
from 50 % to 70 % (Figure 10A, F). Similarly, the fraction of alignments to mRNA genes 
in the YTHDF2 and YTHDF3 samples rose to 75 % and 73 % respectively (Figure 10B, 
C). Furthermore, YTHDC1 also showed an 11 % increase to 61 % in mRNA alignments 
compared to the FLAG control (Figure 10D). An increase in the number of reads 
mapping to tRNA genes was seen for YTHDF1 (14 %), YTHDF2 (8 %), YTHDF3 (10 %) 
and YTHDC2 (38 %), compared to the FLAG control (6 %) (Figure 10A-F). However, an 
increase in the proportion of reads mapping to tRNAs has also previously been seen in 
other PAR-CRAC samples of RNA-binding proteins (data not shown), suggesting that it 
can be non-specific. Since this is particular significant for YTHDC2, the distribution of the 
reads among the tRNA genes was analysed and compared to the control. The 
distribution did not show any substantial changes, further supporting that the increase is 
unspecific. Interestingly, YTHDC2 was the only sample that showed an increase in the 
proportion of reads corresponding to rRNA sequences compared to the FLAG control 
(Figure 10E-F). To determine whether this subtle enrichment of rRNA sequences in the 
YTHDC2 PAR-CRAC sample was reproducible, a second CRAC experiment was 
conducted with the YTHDC2-FLAG cell lines using an alternative cross-linking method 
(UV-CRAC). Mapping and analysis of the data obtained from this experiment 
demonstrated an even more prominent enrichment of rRNA sequences in the YTHDC2-
FLAG sample compared to the FLAG control (Figure 10G-H). Indeed, reads mapping to 
the rDNA represented 36 % of total reads compared to only 13 % in the corresponding 
FLAG control.  
Figure 9: YTH domain-containing proteins cross-link to 
cellular RNAs. HEK293 cells expressing FLAG-tagged YTH 
domain-containing proteins were grown in media containing  
4-thiouridine and RNAs were cross-linked using light at 
365 nm. After affinity purification and trimming, the 5’ ends of 
the co-purified RNAs were radioactively labelled. RNA-protein 
complexes were separated by NuPAGE, transferred to a nylon 
membrane and visualised by autoradiography. 
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Figure 10: Genome-wide mapping of YTH domain-containing protein CRAC data. 
(legend on next page) 
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A-F HEK293 cells expressing YTHDF1-FLAG (A), YTHDF2-FLAG (B), YTHDF3-FLAG (C), YTHDC1-FLAG 
(D), YTHDC2-FLAG (E) or the FLAG-tag alone (F) were grown in media containing 4-thiouridine and RNAs 
were cross-linked using light at 365 nm (see also Figure 9). The RNA-protein complexes were affinity 
purified, the co-purified RNA was trimmed, the 5’ ends of were radioactively labelled and adapters were 
ligated to both ends of the RNA. RNA-protein complexes were separated by NuPAGE, transferred to a nylon 
membrane and visualised by autoradiography. The RNA was eluted from the RNA-protein complexes on the 
nylon membrane and transcribed into cDNA for sequencing library preparation and Illumina next-generation 
sequencing. The pie charts represent different RNA classes and the relative distribution of sequencing reads 
that was obtained after mapping of the reads to the human genome. Abbreviations: mRNA, messenger RNA; 
tRNA, transfer RNA; snRNA, small nuclear RNA; snoRNA, small nucleolar RNA; rRNA, ribosomal RNA; 
mitoRNA, mitochondrial-encoded RNA; miscRNA, miscellaneous RNA; miRNA, microRNA; lncRNA, long 
non-coding RNA. G-H HEK293 cells expressing YTHDC2-FLAG (G) or the FLAG-tag alone (H) were UV 
cross-linked at 254 nm and treated otherwise as in A-F. 
Taken together, the CRAC data show an overrepresentation of reads mapping to protein-
coding genes (mRNAs) for YTHDF1, YTHDF2, YTHDF3 and YTHDC1, which is in line 
with the earlier publications of YTHDF2 and YTHDC1 (Hartmann et al., 1999; Wang et 
al., 2014a). During this study, two additional reports were published using the CLIP 
method to identify genome-wide RNA substrates of YTHDF1 and YTHDC1 (Wang et al., 
2015; Xiao et al., 2016). There, YTHDF1 was identified as an mRNA binding translation 
enhancer and it was confirmed that YTHDC1 is involved in pre-mRNA splicing, 
consequently supporting the elevated mRNA levels found in the PAR-CRAC experiments 
seen in Figure 10. Similar to YTHDF1 and YTHDF2, YTHDF3 is also likely to recognise 
m6As in mRNAs due to the increased proportion of reads mapping to mRNAs and the 
cytoplasmic localisation of the protein. This fact makes the rRNA increase of YTHDC2 
even more interesting because it is the only YTH domain-containing protein with an 
elevated level of reads mapping to rRNA, suggesting a specific interaction with ribosomal 
RNA. 
Since YTHDC2 showed an increase in the proportion of reads mapping to the rDNA, the 
next step was to check for the accumulation of reads at specific sites on the rDNA.  
A multiple sequence alignment of the FLAG and YTHDC2-FLAG PAR-CRAC data on the 
human ribosomal DNA complete repeating unit was done and the accumulation of reads 
was mapped at single nucleotide level within the region of the cDNA repeat from which 
the 47S pre-rRNA is described (Figure 11). High accumulation of reads (peaks) 
corresponds to potential protein cross-linking sites on the RNA. YTHDC2 showed distinct 
and specific peaks in regions coding for the mature rRNAs on the repeat, but not in the 
spacer regions (Figure 11A). The main cross-linking site of YTHDC2 is located at the 
3’ end in the mature 18S rRNA (Figure 11B). In accordance, an increased mutation rate 
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Figure 11: Profile of YTHDC2 PAR-CRAC hits on pre-rRNA. A Sequence read distribution of YTHDC2-
FLAG (YTHDC2, black plot) or FLAG-tag (FLAG, grey plot) PAR-CRAC samples mapped to the rDNA gene 
encoding the 47S pre-rRNA. The accumulation of sequence reads on the y-axis is normalised to the total 
number of mapped sense-reads (see also Figures 9 and 10E-F). The asterisks mark background peaks also 
present in samples derived from cells expressing the FLAG-tag only. A representation of the 47S pre-rRNA is 
shown below indicating the positions of the mature rRNAs as rectangles and externally and internally 
transcribed spacers as lines on the x-axis. Abbreviations. ETS, external transcribed spacer; ITS, internal 
transcribed spacer; nt, nucleotides. B Magnified view of the 18S rDNA sequence depicted in A. The x-axis 
represents the nucleotide numbering of 18S rDNA. The y-axis of the upper diagram is the same as in A.  
The lower diagram indicates the position of T to C mismatches between sequence reads and the genomic 
sequence for YTHDC2-FLAG (YTHDC2, black plot) or FLAG-tag alone (FLAG, grey plot). 
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of distinct thymine residues was detected within the cross-linking site, confirming the 
specificity of the peak (Figure 11B lower panel). Interestingly, the YTHDC2 cross-linking 
site is localised close to the 3’-end of the 18S rRNA similar to the location of the m6A 
modification. Cross-linking of YTHDC2 close or at this modification site would be in line 
with the putative function of the YTH domain recognising the m6A modification, however, 
the cross-linking site of YTHDC2 and the m6A modification are separated by about 150 nt 
in the rRNA sequence. To analyse whether the modification is close to the cross-linking 
site in 2D or 3D, the YTHDC2-FLAG CRAC data were mapped onto the 2D structure of 
the 18S rRNA (Petrov et al., 2014) and the 3D structure of the SSU of the human 
ribosome (PDB 4V6X, Anger et al., 2013). The number of sequence reads mapped per 
nucleotide is represented by a colour gradient from orange to red, red representing the 
highest accumulation of sequence reads normalised to 100 % (Figure 12 and 13). 
Analysis of the 2D mapping revealed that the YTHDC2 cross-linking site covers the stem 
loop structure of helix 43, which is in the vicinity of the m6A1832 at the 3’ end of 18S 
(Figure 12). Additionally, mapping on the 3D structure confirmed this observation and 
showed that the cross-linking site is in close proximity to helices 41 and 42, and helices 
28 and 29 (Figure 13). Therefore, YTHDC2 cross-links to the “head” region of the SSU 
and the YTH domain of YTHDC2 could very well recognise the m6A modification at the 
end of the 18S rRNA. 
 
Figure 12: Mapping of YTHDC2 PAR-CRAC data onto the human 18S rRNA secondary structure. The 
sequence read distribution of YTHDC2-FLAG PAR-CRAC data (see Figure 11) were mapped on the 
secondary structure of the human 18S rRNA (Petrov et al., 2014). Cross-linking sites are coloured from 
orange (30 %) to red (100 %) and normalised to the highest peak on the 18S rDNA, the highest peak being 
100 %. Residues containing more than 10 % T to C mismatches are coloured in blue. The m6A-modified 
residue is coloured in green. 
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Figure 13: Mapping of YTHDC2 PAR-CRAC data on the 3D structure of the human 18S rRNA. The read 
distribution of YTHDC2-FLAG (see Figure 11) was mapped on the 3D structure of the human 18S rRNA 
(PDB 4V6X, Anger et al., 2013). Cross-linking sites are coloured from orange (30 %) to red (100 %) and 
normalised to the highest peak on the 18S rRNA, the highest peak being 100 %. The A1832 residue, which 
carries an m6A modification, is highlighted in green. 
3.3 YTHDC2 associates with ribosomal complexes 
The next step was to verify the association of YTHDC2 with the ribosome suggested by 
the CRAC analysis with different methods. The large size of ribosomal and pre-ribosomal 
complexes enables the separation of these complexes from free proteins and small 
complexes by sucrose gradient density centrifugation. The small (SSU; 40S) and large 
(LSU; 60S) ribosomal subunits as well as assembled 80S ribosomes have distinct 
migration patterns within the gradient allowing the differentiation of proteins associating 
with the different subunits. Furthermore, the availability of an antibody against YTHDC2 
made it possible to investigate the association of the endogenous protein with ribosomal 
complexes in wild type (WT) cells. 
Thus, sucrose gradient density centrifugation was performed using HEK293 WT cells 
and YTHDF2-FLAG cells, in which fusion protein expression had been induced for 36 h 
before cell harvesting, were used as a control. Whole cell lysates of HEK293 WT and 
YTHDF2-FLAG cells were prepared and loaded on a 10-45 % sucrose gradient followed 
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by overnight ultracentrifugation to separate ribosomal and non-ribosomal fractions. After 
fractionation of the gradient into 23 fractions, the A260 of each fraction was measured. 
This estimate of the RNA content was used to generate a profile and determine which 
fractions contained the 40S and 60S subunits and 80S monosomes (Figure 14 upper 
panel). Afterwards, the protein content of each fraction was analysed by SDS-PAGE 
followed by western blotting (Figure 14 lower panels). The αFlag antibody, which 
detected the YTHDF2-FLAG, showed a signal exclusively in fractions containing non-
ribosomal complexes (Figure 14 bottom western blot). This is in line with the 
overrepresentation of mRNA alignments seen in the YTHDF2 CRAC, data because 
mRNPs are enriched in these fractions (see Figure 10B, F). In contrast, the αYTHDC2 
antibody shows an extensive signal for YTHDC2 in the fractions containing ribosomal 
complexes with distinct peaks in fractions 11-13 and fraction 17 (Figure 14 top western 
blot). Interestingly, these fractions contain the 40S subunit (fractions 11-13) and the 80S 
ribosome (fraction 17) meaning that all of these fractions contain SSU particles, which is 
in line with the identification of a cross-linking site for YTHDC2 at the 3’ end of 18S rRNA 
sequence (see Figure 10E-H).  
 
Figure 14: YTHDC2 is associated with ribosomal complexes. Whole cell lysates from wild type HEK293 
cells or cells expressing YTHDF2-FLAG were separated by sucrose gradient density centrifugation. Fractions 
were taken manually and A260 measurements of the fractions were used to generate an RNA profile from 
which the fractions containing different ribosomal complexes could be determined (indicated below the 
profile). Proteins in the different fractions were TCA precipitated, separated by SDS-PAGE and subjected to 
western blotting (bottom). Endogenous YTHDC2 was detected using an αYTHDC2 antibody. YTHDF2-FLAG 
was detected using an αFlag antibody. 
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Having confirmed the association of YTHDC2 with the ribosome, the next step was to 
identify the region of the protein that is responsible for this interaction. YTHDC2 is a large 
protein with a calculated mass of 160 kDa and has a multi-domain structure. In silico 
sequence homology analysis identified three domains, a N-terminal R3H domain, a 
putative RNA helicase domain and a C-terminal YTH domain (Figure 15A, UniProt, 
2015). The R3H domain is a general nucleic acid binding domain, with a preference for 
binding guanine residues (Jaudzems et al., 2012). RNA helicase domains are generally 
involved in altering RNA-RNA and RNA-protein interactions (reviewed in Bleichert and 
Baserga, 2007) and in other proteins, the YTH domain has been shown to recognise m6A 
modifications in RNAs (Xu et al., 2015). To investigate if either of the two terminal RNA-
binding domains is responsible for the interaction of YTHDC2 with the ribosome, 
constructs for the expression of truncated versions of YTHDC2 were generated.  
The DNA sequences coding for amino acids 192-1430 (∆R3H) or amino acids 1-1287 
(∆YTH) of YTHDC2 (Figure 15A) were cloned into the pcDNA5 vector adding the 
sequence of a C-terminal FLAG-tag to the CDS. The CDSs were genomically integrated 
into the genome of HEK293 Flp-In T-Rex cells to generate stable cell lines as previously 
described. To test expression of the truncated proteins, the cell lines were grown in the 
presence or absence of doxycycline for 24 h, whole cell lysates were prepared and 
separated by SDS-PAGE and tagged proteins were detected by western blotting using 
an αFlag antibody. A signal could be detected at the correct size in cells grown in the 
presence of doxycycline confirming the correct expression of the inserted sequence 
(Figure 15B). CRAC experiments were therefore conducted with these cell lines after 
inducing ∆R3H-FLAG or ∆YTH-FLAG expression for 36 h similar to the PAR-CRAC 
experiments of the YTH domain-containing proteins before and analysed similarly (Figure 
15C and D). The stable cell line expressing full-length YTHDC2-FLAG was included as a 
positive control. Analysis of the distribution of the sequence reads obtained for YTHDC2-
FLAG between the different RNA classes showed that the portion of reads mapping to 
rDNA sequences was similar to the first YTHDC2-FLAG PAR-CRAC experiment. 
Interestingly, the rRNA portion is reduced to 3.5 % in the ΔR3H sample (Figure 15E). 
Mapping of this data onto the 18S rRNA sequence of the rDNA repeat confirmed this as, 
compared to YTHDC2-FLAG sample (black plot), the ∆R3H-FLAG sample (red plot) 
showed a reduced peak at the end of 18S rRNA (Figure 15C). This suggests that the 
R3H domain is involved in the interaction of YTHDC2 with the ribosome. In contrast, the 
∆YTH-FLAG sample showed a similar fraction of reads mapped to rDNA (8 %) as full-
length YTHDC2 (Figure 15E). Also, the profile along the 18S rRNA sequence of 
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Figure 15: The R3H domain of YTHDC2 contributes to the association with the ribosome. A Schematic 
representation of the domain structure of YTHDC2. The putative R3H domain (red), the RNA helicase core 
domain (green) and the YTH domain (blue) are indicated. The bars below represent the boundaries of the 
truncation constructs. ∆R3H, truncation of the R3H domain (YTHDC2192-1430); ∆YTH, truncation of the YTH 
domain (YTHDC21-1287). B Whole cell lysate from HEK293 cell lines expressing ΔR3H-FLAG (ΔR3H) or 
ΔYTH-FLAG (ΔYTH) was prepared, separated by SDS-PAGE and subjected to western blotting. The cells 
were induced (+) for 24 h with doxycycline (Dox) or untreated (-). The FLAG-tagged proteins were detected 
using an αFlag antibody. Tubulin was used as a loading control and detected with an αTubulin antibody. 
(legend continued on the next page) 
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D-C HEK293 cells expressing ΔR3H-FLAG (ΔR3H, red plot, C), ΔYTH-FLAG (ΔYTH, blue plot, D) or full 
length YTHDC2-FLAG (YTHDC2, black plot, C and D) were grown in media containing 4-thiouridine and 
RNAs were cross-linked using light at 365 nm. After trimming, the 5’ ends of the co-purified RNAs were 
radioactively labelled and adapters were ligated to both ends. RNA-protein complexes were separated by 
NuPAGE, transferred to a nylon membrane and visualised by autoradiography. The RNA was eluted from 
the RNA-protein complexes on the nylon membrane and transcribed into cDNA for sequencing library 
preparation and Illumina next-generation sequencing. The plot represents the sequence read distribution on 
the human 18S rDNA normalised to the total number of mapped sense-reads. The lower diagram indicates 
the position of T to C changes in sequence reads compared to the genomic sequence for ΔR3H-FLAG 
(ΔR3H, red plot, C) or ΔYTH-FLAG (ΔYTH, blue plot, D). Abbreviation: nt, nucleotides. E Relative abundance 
of sequence reads mapped to rDNA for full-length YTHDC2-FLAG (YTHDC2, black), ΔR3H-FLAG (ΔR3H, 
red) and ΔYTH-FLAG (ΔYTH, blue) PAR-CRAC data shown in C and D. The data is normalised to the total 
number of mapped sense-reads. 
the ∆YTH sample (blue plot, Figure 15D) is similar to that of the YTHDC2 sample (black 
plot, Figure 15D) including the peak at the 3’ end of the 18S rRNA sequence. The CRAC 
analyses of the truncated versions of YTHDC2 therefore suggest that the R3H RNA-
binding domain facilitates the contact between YTHDC2 and the 18S rRNA, whereas 
deletion of the YTH domain has no effect on the interaction seen in the CRAC analysis. 
 
3.4 The YTH domain of YTHDC2 recognises the 18S m6A in vitro 
The interaction of YTHDC2 with the ribosome could be verified in vivo by two 
independent methods, namely CRAC experiments and sucrose density gradients. 
However, CRAC of the ∆R3H-FLAG and ∆YTH-FLAG cell lines suggests that the R3H 
domain is primarily responsible for ribosome interaction of YTHDC2 and that the YTH 
domain does not significantly contribute to the association of this protein with the 
ribosome. Given that in other proteins, the YTH domain has been shown to specifically 
bind m6A modifications and that the cross-linking site of YTHDC2 is in close proximity to 
the 3’ end of the 18S rRNA where such a modification has been reported, this raises the 
possibility that the YTH domain of YTHDC2 “reads” the m6A modification in the 18S 
rRNA.  
To test this possibility, in vitro anisotropy experiments were carried out to first test the 
affinities of the YTH domain of YTHDC2 for N6-methyadenosine-containing RNA. 
Therefore, the YTH domain of YTHDC2 (amino acids 1277-1430) was cloned into a 
pQE80-vector derivative (A21) for expression of this protein domain with an N-terminal 
His10-Zz-TEV protease site (HZZT)-tag. Also, the YTH domains of YTHDF2 (amino acids 
380-579) and YTHDC1 (amino acids 344-509) were cloned into the same vector, 
because they could serve as a positive control, since they have previously been shown 
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to specifically bind m6A-containing RNA (Li et al., 2014; Xu et al., 2014). The boundaries 
were chosen according to the published crystal structures of YTHDC1 and YTHDF2  
(Xu et al., 2015; Xu et al., 2014) or homology sequence alignments in the case of 
YTHDC2. The proteins were expressed in Escherichia coli and purification was 
established (Figure 16).  
The majority of the m6A modifications are found in the sequence context GG(m6A)CU 
(Dominissini et al., 2012), which can be recognised by the YTH domains of YTHDF2 and 
YTHDC1 (Xu et al., 2015). Anisotropy measurements were carried out to measure 
binding of the YTH domains to 9 nucleotide long single stranded RNA oligonucleotide 
labelled at the 5’ end with fluorescein containing this sequence motif either with or 
without m6A modification (Figure 17). Strong binding could be detected for HZZT-
YTHDF2380-579 (Kd 0.019 ± 0.003 µM) and HZZT-YTHDC1344-509 (Kd 0.043 ± 0.004 µM) to 
the modified GG(m6A)CU. No binding could be detected for HZZT-YTHDF2380-579 to the 
unmodified sequence and only very low binding of HZZT-YTHDC1344-509 (Kd 33 ± 8) 
(Figure 17A, B, D), confirming that the YTH domains of YTHDC1 and YTHDF2 
specifically recognise the m6A modification and establishing conditions with which the 
affinity of the YTH domain of YTHDC2 for the modified and unmodified sequence could 
be monitored. The Kd of YTHDC2 to the modified sequence was found to be 
3.19 ± 0.27 µM while the affinity of the YTH domain of YTHDC2 for the unmodified 
sequence was so low that a Kd value could not be determined (Figure 17C, D).  
This demonstrates that similar to the YTH domains of YTHDF2 and YTHDC1, the YTH 
domain of YTHDC2 also specifically recognises this modification. Notably however, in 
these experiments, the YTH domain of YTHDC2 displayed a significantly lower binding 
affinity for the m6A-modified oligonucleotide than the YTH domains of YTHDC1 of 
YTHDF2.  
Figure 16: Recombinant expression of YTH 
domains. Recombinantly expressed, HZZT-tagged 
fragments of the indicated proteins corresponding 
to the YTH domains were purified, separated by 
SDS-PAGE and visualised with Coomassie 
staining. W1310A and W1360A are versions of 
YTHDC21277-1430 with tryptophan to alanine 
substitutions of the amino acids corresponding to 
positions 1310 or 1360 of the full-length protein. 
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Figure 17: The YTH domain of YTHDC2 recognises the m6A modification. A-C A fluorescine-labelled 
single stranded 9 nucleotide RNA containing the GGACU mRNA sequence in which the “A” was either 
unmodified (red circles) or carried an m6A modification (black squares) was incubated with HZZT-
YTHDF2380-579 (A), HZZT-YTHDC1344-509 (B) or HZZT-YTHDC21277-1430 (C) at the indicated concentrations 
and fluorescence anisotropy was measured. D The dissociation constants (Kd) of the experiments shown in 
A-C are given. In cases of negligible protein binding to the RNA Kd values could not be determined (n.d.). 
The finding that YTHDC2 is associated with the ribosome and cross-links to the 3’ end of 
the 18S rRNA in close proximity to the m6A modification present there, suggests that this 
modification could be recognised by the YTH domain of YTHDC2. Interestingly, the m6A 
modification in the 18S rRNA is present in a different sequence motif UA(m6A)CA than 
the majority of other m6A modifications. Therefore, anisotropy measurements were 
performed to test the relative affinities of the different YTH domains for the m6A 
modification in these two alternative sequence contexts (Figure 18). This showed that, 
compared to the GG(m6A)CU motif, the Kd of HZZT-YTHDF2380-579 for the UA(m6A)CA 
motif increased significantly to 0.058 ± 0.003 µM (p<0.0001; Students t test) (Figure 18A, 
B). Similarly, for the UA(m6A)CA motif, the Kd of HZZT-YTHDC1344-509 increased to 
0.256 ± 0.009 µM (p<0.0001, Students t test) (Figure 18B, D), demonstrating a clear 
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reduction in binding affinity of these YTH domains to the m6A modification in the 18S 
rRNA sequence context, as compared to the classical GG(m6A)CU motif identified for 
most m6A modifications in mRNAs. In contrast, the Kd of HZZT-YTHDC21277-1430 
significantly decreased to 2.57 ± 0.18 µM (p=0.0297; Students t test) showing opposite 
effects when interacting with the modified 18S rRNA sequence (Figure 18C, D). This 
means that the YTH domain of YTHDC2 is the only protein that shows an increased 
binding to the m6A modification in the 18S rRNA sequence context, further supporting a 
model in which YTHDC2 associates with the ribosome and would recognise this 
modification. Furthermore, the YTH domain of YTHDC1 strongly selects against this 
sequence context for m6A binding suggesting that it is highly specialised for recognition 
of the m6A modification in the mRNA/GG(m6A)CU context. 
 
Figure 18: The YTH domain of YTHDC2 recognise the m6A in the 18S rRNA sequence context with 
higher affinity than the m6A in the consensus motif. A-C A fluorescine-labelled single stranded 9 
nucleotide RNA containing the modified UA(m6A)CA 18S rRNA sequence (green triangles) was incubated 
with HZZT-YTHDF2380-579 (A), HZZT-YTHDC1344-509 (B) or HZZT- YTHDC21277-1430 (C) at the indicated 
concentrations and fluorescence anisotropy was measured. For comparison the data of the proteins binding 
to the modified GG(m6A)CU mRNA sequence are shown again (see Figure 17, black squares) D The 
dissociation constants (Kd) of the experiments shown in A-C are given. 
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To identify key residues in the YTH domain of YTHDC2 that contribute to m6A 
recognition, the amino acid sequences of these three YTH domains were aligned and 
analysed with the multiple sequence aligner MUSCLE (Figure 19, Edgar, 2004). This 
revealed that the YTH domains of YTHDC2 and YTHDC1 are 49.25 % identical, whereas 
the YTH domain of YTHDF2 shares only 32.84 % sequence identity. Interestingly, the 
tryptophan residues W432, W486 and W499 in YTHDF2 and W377, W428 and W447 in 
YTHDC1, which were shown to form the aromatic cage and mediate the m6A interaction 
(Xu et al., 2014; Zhu et al., 2014) are also conserved in YTHDC2 (W1310, W1360 and W1373; 
arrows, Figure 19). To test whether these residues also contribute to the binding of the 
YTH domain of YTHDC2 to the m6A in the 18S rRNA sequence context, two of the 
tryptophan residues, W1310 and W1360, were mutated to alanine (Figure 19, red arrows). 
Proteins containing the mutations were expressed and purified (Figure 16) and additional 
anisotropy experiments were performed to monitor association with the RNA 
oligonucleotide containing the m6A modification in the 18S rRNA sequence motif. 
Interestingly, both mutations abolished the binding to the m6A modification implying that 
the YTH domain of YTHDC2 interacts with the m6A modification in a similar manner as 
the other YTH domain-containing proteins (Figure 20). 
 
Figure 19: Sequence alignment of the YTH domains found in human proteins. Sequence alignment of 
the YTH domains of YTHDC2, YTHDC1 and YTHDF2 by the multi sequence aligner MUSCLE visualised with 
ESPript 3.0. The secondary structural features of the YTH domain of YTHDC2 (PDB 2YU6) are shown above 
the corresponding amino acids. Amino acids that are conserved in all three protein domains are shown with 
a red background and the red arrows indicate tryptophan 1310 and 1360 of YTHDC2. The black arrow 
indicates tryptophan 1373 of YTHDC2. 
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Figure 20: W1310 and W1360 of the YTH domain of YTHDC2 are required for binding to m6A. A A 
fluorescine-labelled single stranded 9 nucleotide RNA containing the modified UA(m6A)CA 18S rRNA 
sequence was incubated with HZZT-YTHDC21277-1430 containing either the W1310A substitution (green) or 
W1360A substitution (blue). Incubation with the wilde type protein (WT, black squares) is shown as a 
comparison (see Figure 18). B The dissociation constant (Kd) of the WT YTHDC2 experiment shown in A is 
given. 
Together these results confirm that the YTH domain of YHTDC2 can specifically bind 
m6A modified RNAs and that it has a significantly higher affinity to the modification in the 
sequence context of the 18S rRNA, implying that it may function as a reader of this 
modification in the cell. Mutational analysis showed that YTHDC2 has probably a similar 
binding mechanism for m6A modified RNA as the other YTH domain-containing proteins. 
 
3.5 Analysis of the cellular function of YTHDC2 
The data show that YTHDC2 associates with ribosomal complexes, likely via its R3H 
domain and the YTH domain can specifically recognise the m6A modification, with an 
increased affinity for modified nucleotide in the sequence context of the rRNA.  
This raises the question of what the function of such interactions might be in the cell.  
The immunofluorescence experiments showed that YTHDC2 predominantly localises to 
the cytoplasm but a fraction of the protein is also present in the nucleus (Figure 8). 
Together with the partially enclosed localisation of the m6A modification of the 18S rRNA 
in the mature ribosome, this lead to the hypothesis that it might be involved in ribosome 
biogenesis and may be recognising the 18S rRNA m6A modification in a pre-ribosomal 
complex. Sucrose density gradients could not answer the question whether YTHDC2 
interacts with pre-ribosomal complexes or the mature ribosome, because both particles 
are located in similar fractions. Therefore, to determine if YTHDC2 is required for 
ribosome biogenesis, YTHDC2 was depleted from human cells by RNAi and effects on 
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the levels of precursor rRNAs and newly synthesised rRNAs were monitored by northern 
blotting and pulse-chase labelling experiments, respectively.  
First, the knockdown efficiency of three independent siRNAs targeted against YTHDC2 
mRNA (siYTHDC2_1, siYTHDC2_2, siYTHDC2_3) was tested. HeLa cells were 
transfected with 30 nM siRNA and after 96 h, total cellular RNA was isolated. Analysis by 
RT-qPCR showed that the level of the YTHDC2 mRNA in cells that had been transfected 
with siRNAs against YTHDC2 were reduced to 15-25 % of the level in wild-type cells or 
of cells that had been treated with the control siRNA. GAPDH and Tubulin mRNAs were 
used for normalisation of different cDNA concentrations (Figure 21A). In parallel, siRNA-
treated cells were used to prepare whole cell extracts that were separated by SDS-PAGE 
and analysed by western blotting using antibodies against YTHDC2 and Tubulin as a 
loading control. In extracts from cells that had been transfected with siRNAs against 
YTHDC2, no signal could be detected for endogenous YTHDC2 using the αYTHDC2 
antibody, showing that the knockdown leads to efficient protein depletion (Figure 21B). 
Having established suitable knockdown conditions, northern blots were prepared to 
visualise accumulation or depletion of rRNA precursors. Therefore, human cells were 
treated with the three different siRNAs against YTHDC2 and a control siRNA. Total 
cellular RNA was extracted, separated on an agarose-glyoxal gel and transferred to a 
membrane. Two DNA probes complementary to sequences either in ITS1 or ITS2 
(depicted as red asterisks in Figure 22A) were used for monitoring SSU or LSU pre-rRNA 
processing. A probe recognising the actin mRNA was used as a loading control as well 
Figure 21: Establishment of RNAi against YTHDC2. A HEK293 cells were transfected with 30 nM of the 
indicated siRNA and after 96 h, RNA was isolated and used to generate cDNA. The levels of the YTHDC2 
mRNA were determined by RT-qPCR and the levels of the GAPDH and Tubulin mRNAs were used for 
normalisation. B HEK293 WT cells were transfected with 30 nM of the indicated siRNA and after 96 h cells 
were harvested. Whole cell extract was prepared, separated by SDS-PAGE and analysed by western 
blotting using an αYTHDC2 antibody, or an αTubulin antibody as a loading control. 
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as methylene blue staining of mature 18S and 28S rRNA (Figure 22B). No changes in 
the levels of any pre-rRNA species could be detected while comparing knockdown 
samples (siYTHDC1_1, siYTHDC2_2, siYTHDC2_3) and control (siControl) or wild-type 
(WT) sample (Figure 22B), suggesting that ribosome biogenesis is not altered upon 
knockdown of YTHDC2. However, northern blots represent a steady state level of pre-
cursor RNAs in which aberrant pre-rRNAs might have already been degraded by the 
RNA surveillance machinery, therefore, the next step was to investigate pre-RNA 
processing via pulse-chase experiments. 
Pulse-chase experiments have a higher sensitivity, because only nascent rRNA 
transcripts are detected and this method can enable visualisation of subtle processing 
defects that effect mature rRNA abundance or the ratio of SSU to LSU maturation. 
Therefore, human cells were treated with siRNAs as described for the northern blotting. 
Then, cells were grown in the absence of phosphate to deplete the cells of  
non-radioactive phosphate. The medium was removed and the cells were grown in the 
presence of radioactively labelled phosphate (pulse) followed by cultivation in normal cell 
culture growth medium (chase). During the pulse, nascent RNA chains are labelled 
radioactively by the incorporation of radioactive phosphate. Then cellular RNA was 
extracted, separated on an agarose-glyoxal gel, transferred to a membrane and 
abundant, labelled RNAs were visualised using a phosphorimager (Figure 22C). The top 
panel of Figure 22C shows the signals of radioactively labelled 47S and 32S pre-rRNAs, 
and the mature 18S and 28S rRNAs. The ratio between the mature 18S and 28S rRNAs 
in the samples derived from cells treated with siRNAs against YTHDC2 was not changed 
compared to the control and WT cells, thus indicating that depletion of YTHDC2 does not 
specifically effect the maturation of one of the ribosomal subunits. Also, a general defect 
of rRNA maturation was not detected, because the total amount of radioactively labelled 
mature rRNAs was not altered by the siRNA treatment considering the UV loading 
control representing total amounts of 18S and 28S rRNA.  
These results show that knockdown of YTHDC2 has no significant effect on pre-rRNA 
processing implying that this protein is not required for ribosome biogenesis and 
therefore likely predominantly interacts with mature ribosomes. However, mature 
ribosomes are present in large quantities in the cell and exceed the amount of YTHDC2. 
Therefore, it is very likely that YTHDC2 only interacts with a sub-population of 
cytoplasmic ribosomes. To identify this sub-population and gain more information about 
the function of YTHDC2, the next aim was to identify additional protein interaction 
partners. 
Results 
 67 
 
Figure 22: Depletion of YTHDC2 does not affect pre-rRNA processing. A Simplified scheme of pre-rRNA 
processing in human cells. The mature rRNAs are shown as rectangles and the internal and external 
transcribed spacers (ITS and ETS, respectively) are shown as lines. The binding sites of the probes used for 
northern blotting are indicated with red asterisks. B HEK293 cells were treated with 30 nM of the indicated 
siRNAs for 96 h. Total cellular RNA was isolated and subjected to northern blot analysis using the probes 
indicated to the right of the panel with the binding sites shown in A. Northern blotting using a probe against 
the actin mRNA was used as a loading control and mature rRNAs were visualised by methylene blue staining 
(MB). C HEK293 cells were treated with 30 nM of the indicated siRNAs for 96 h. Then the cells were pulse-
labelled with 32P-orthophosphate for 1 h and then grown in unlabelled media for 3 h before isolation of 
cellular RNA. The upper panel shows the newly synthesised radioactively labelled RNA (pulse-chase), the 
lower panels show the total amount of mature rRNA visualised by UV light (UV). 
 
To get an overview of the protein-interactome of YTHDC2 immunoprecipitation (IP) of 
YTHDC2-containing complexes was performed, followed by the identification of the co-
precipitated proteins using mass spectrometry. For this stable cell lines expressing 
YTHDC2-FLAG or the FLAG-tag alone were induced for 36 h, whole cell lysate was 
prepared and the complexes were purified using immobilised αFlag antibodies. Eluates 
were then separated by NuPAGE and analysed by mass spectrometry in collaboration 
with the group of Prof. Dr. Henning Urlaub. Analysis of the data showed that the 
cytoplasmic 5’-3’ exonuclease XRN1 was the most enriched protein co-
immunoprecipitating with YTHDC2-FLAG compared to the FLAG control, suggesting a 
stable interaction between YTHDC2 and XRN1. To confirm this interaction, 
immunoprecipitation assays of YTHDC2-FLAG were repeated and analysed by western 
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blotting using an αXRN1-specific antibody (Figure 23). Cell lines expressing FLAG-
tagged version of other YTH domain-containing proteins (YTHDC1-FLAG, YTHDF1-
FLAG, YTHDF2-FLAG and YTHDF3-FLAG) were included as additional controls to 
determine if the putative interaction with XRN1 is specific for YTHDC2-FLAG. 
Immunoprecipitation assays were performed as described above. In addition, a mix of 
RNase A and T1 was added to half of the sample to abolish RNA-mediated interactions 
by the digestion of cellular RNAs. The input, and the eluate from samples with and 
without RNase treatment, were then separated by SDS-PAGE and analysed by western 
blotting. Only the YTHDC2-FLAG IP shows a specific signal for XRN1 confirming the 
interaction detected by mass spectrometry and demonstrating the specificity of this 
interaction (Figure 23A). Also, addition of RNase during the purification did not disrupt 
the interaction, indicating that it is an RNA-independent protein-protein interaction.  
 
Figure 23: YTHDC2 associates with the cytoplasmic 5’-3’ exonuclease XRN1. A Extracts from stable cell 
lines expressing the FLAG-tag alone (FLAG) or FLAG-tagged version of the indicated proteins were used for 
immunoprecipitation experiments. Protein-complexes were purified using an immobilised αFlag antibody. 
Inputs (1%) and elutions (IP) were analysed by western blotting using an αXRN1 antibody. Cell lysates were 
either treated with RNase (+) or left untreated (-) prior to immunoprecipitation. B Immunoprecipitation 
experiments were performed and analysed as in A, without RNase treatment, using extracts prepared from 
cells expressing the FLAG-tag alone (FLAG), full-length YTHDC2 (YTHDC2) or truncated version of 
YTHDC2 lacking the R3H-domain (ΔR3H) or the YTH domain (ΔYTH) (see Figure 15). 
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To gain more information about the YTHDC2 domain that forms contacts with XRN1, 
additional immunoprecipitation experiments were performed as described above using 
cell lines expressing the truncated FLAG-tagged versions of YTHDC2, i.e. ∆R3H-FLAG 
and ∆YTH-FLAG. Input and eluates were separated by SDS-PAGE and analysed by 
western blotting using an antibody against endogenous XRN1. In addition to the full-
length protein, XRN1 was co-precipitated with ∆R3H-FLAG and ∆YTH-FLAG, indicating 
that XRN1 interacts with the central domain of the protein (Figure 23B). This is in line 
with the fact that the R3H and YTH domains are RNA-interaction domains, which have 
so far not been suggested to be involved in forming protein-protein interactions 
(Jaudzems et al., 2012; Xu et al., 2015). The interaction of YTHDC2 with the ribosome in 
combination with the exonuclease XRN1 suggest that the function of YTHDC2 and the 
recognition of the m6A could be in rRNA degradation and quality control. 
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4 Discussion 
4.1 Development of computational tools for the transcriptome-wide 
analysis of the RNA targets of RNA-modifying enzymes  
In addition to the long known “epigenetic” methylations in DNA and various post-
translational modifications of proteins (e.g. phosphorylation, ubiquitination, acetylation, 
etc.), chemical modifications are also found in most cellular RNAs. A wide variety of such 
RNA modifications exist in nature and in general, they serve to expand the chemical 
properties of the four basic nucleotides, meaning that they can regulate the functions of 
the RNAs that carry them. Many enzymes that mediate RNA modifications contain 
conserved protein domains that harbour their catalytic activity. Although the enzymes 
that are responsible for introducing some RNA modifications are known, the specific 
substrate RNAs and target nucleotides of many other putative RNA modifying enzymes 
remain to be determined.  
The human genome encodes seven 5-methylcytosine (m5C) RNA methyltransferases 
that belong to the Nol1/Nop2/SUN (NSUN) family (reviewed in Motorin et al., 2010).  
So far, proteins of this family have been linked to modifications at specific sites in 
cytoplasmic tRNAs (NSUN2; Brzezicha et al., 2006), mitochondrial and cytoplasmic 
rRNAs (NSUN4, NSUN1 and NSUN5; Camara et al., 2011; Schosserer et al., 2015; 
Sharma et al., 2013b) and enhancer RNAs (NSUN7; Aguilo et al., 2016), but the targets 
of the NSUN6 and NSUN3 m5C RNA methyltransferases remained elusive. A strategy 
that can be used for the identification of the RNAs associated with RNA binding proteins 
is in vivo cross-linking followed by isolation of RNA-protein complexes, isolation of RNA 
and deep sequencing of a corresponding cDNA library (Bohnsack et al., 2012).  
This approach (CRAC) was employed in the Bohnsack lab to identify RNA-interaction 
partners of NSUN6 and NSUN3 (Haag et al., 2016; Haag et al., 2015b). However, the 
identification of the cellular RNAs bound by the proteins in this method requires that the 
obtained sequence reads are quality controlled and mapped to a well annotated version 
of the human genome. Therefore, bioinformatic algorithms and mapping tools were 
employed and further developed to generate a systematic pipeline, specifically adapted 
for the mapping and analysis of CRAC data derived from human cells.  
 Many newly developed techniques for the transcriptome-wide mapping of RNA 
modifications, determining the RNA-interactome of RNA-binding proteins and the 
analysis of gene expression, are based on the analysis of next generation sequencing 
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data (Bohnsack et al., 2012; Darnell, 2012; Hafner et al., 2010; Ingolia et al., 2009; Krogh 
et al., 2016; Nagalakshmi et al., 2008). For example, RNA-Seq, in which total cellular 
RNA (depleted of ribosomal RNA) is isolated, fragmented and sequenced, is used to 
investigate the transcriptome of a cell population at a given time under certain conditions 
(Nagalakshmi et al., 2008), as the relative number of unique sequence reads mapping to 
individual genes allows a quantitative statement about the expression level of the 
corresponding mRNAs. Similarly, ribosome profiling (Ingolia et al., 2009) can provide a 
snapshot of the mRNAs that are being translated in a given cell population by enabling 
sequencing and identification of ribosome-associated mRNAs. The analysis of CRAC 
data relies on similar principles as the sub-population of cellular RNA that is attached to 
the protein of interest is isolated, sequenced and mapped to the genome. The 
accumulation of multiple sequence reads mapping to a specific region of the genome 
then indicates binding of the protein to the corresponding RNA transcript. As RNA 
modifications can occur in the majority of transcripts and are highly abundant in non-
coding RNAs, in contrast to approaches for analysis of RNA-Seq and ribosome profiling 
data, a bioinformatic pipeline for the mapping of CRAC data generated for RNA 
modification enzymes, requires a well-annotated and complete reference genome or 
transcriptome. Another difference between the analysis of CRAC data and the analysis of 
gene expression by RNA-Seq is that in CRAC, the cross-linked RNA-protein complexes 
are purified on matrices and the non-specific binding of RNAs to such beads could lead 
to background. Alternatives to the standard UV254 cross-linking, such as cross-linking 
with light at 365 nm after treatment of the cells with 4-thiouridine (PAR-CRAC), can be 
used to increase the specificity of cross-linking and furthermore, modules were 
developed within the bioinformatic pipeline to enable sorting and mapping of reads 
containing only specific mutations that are introduced by the direct cross-linking of the 
RNA and protein, thereby significantly reducing the non-specific background in the final 
data output of the analysis pipeline.  
Also in contrast to RNA-Seq, in which only the number of reads mapping to the genes 
coding for individual transcripts is considered, one of the aims of CRAC is to identify the 
specific binding site of the protein on the RNA transcript. In the case of the RNA 
methyltransferases NSUN6 and NSUN3, analysis of the read distribution between 
different classes of RNA transcript and between different tRNA genes suggested that the 
cytoplasmic tRNAs tRNACys and tRNAThr are bound by NSUN6 and the mitochondrial 
tRNAMet is associated with NSUN3. These putative target RNAs were confirmed by 
additional in vivo experiments, but close analysis of the distribution of mapped sequence 
reads on the tRNA sequences also provided the basis for the identification of the 
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modification target nucleotides of these enzymes. These could subsequently be 
determined by mutational analysis combined with in vitro methylation assays (Haag et 
al., 2015; Haag et al., 2016). The identification of the specific binding sites of proteins on 
their target RNAs is especially relevant for characterisation of proteins that contact the 
(pre-) ribosomal RNAs and for such proteins, additional scripts were added to the basic 
CRAC pipeline to enable mapping of the obtained sequence reads onto the available  
2D structures of the mature rRNAs and the 3D structure of the human 80S ribosome. 
Such modelling significantly helps the interpretation of the obtained CRAC data, as it 
allows it to be determined if multiple cross-linking sites that may be distant on the linear 
sequence of a particular rRNA come in close proximity to each other on the folded RNA. 
It also enables the identification of other features in close proximity of the protein cross-
linking sites, such as RNA modifications and the binding sites of other proteins that need 
to be considered in the context of the assembled RNP. 
In the case of proteins that cross-link to mRNAs, one of the limitations of the current 
pipeline is the simplification of the annotation of the protein coding genes in the genome 
version to which sequences are mapped. This means that reads mapping to 5’ and 
3’ UTRs cannot be distinguished from reads that map to the coding sequences. Similarly, 
the present pipeline is not able to map exon-exon spanning reads and such information 
can be highly valuable for understanding the functions of proteins involved in mRNA 
processing/mRNP biogenesis and can also be relevant for the analysis of proteins 
involved in RNA modification as an asymmetric distribution of RNA modifications is often 
observed, e.g. m6A modifications are enriched around stop codons, long internal exons 
and in 3’ UTRs (Chen et al., 2015; Dominissini et al., 2012; Linder et al., 2015) and m1A 
modifications are typically clustered in 5’ and 3’ UTRs (Dominissini et al., 2016; Li et al., 
2016). The analysis of such features can be done by using alignment tools, such as 
HISAT2 (Hierarchical Indexing for Spliced Alignment of Transcripts; Kim et al., 2015) or 
STAR (Spliced Transcripts Alignment to a Reference; Dobin et al., 2013) instead of the 
currently used Bowtie sequence alignment tool, as these algorithms are specially 
designed for the alignment of spliced reads spanning exon-exon junctions in mRNA.  
An alternative strategy for the mRNA analysis could be to use a dedicated mapping 
collection, such as HOMER (Hypergeometric Optimization of Motif EnRichment; Heinz et 
al., 2010) that was originally designed to identify binding motifs within deep sequencing 
data but which can also be used for genome-wide analysis of next generation 
sequencing data. Lastly, the recent availability of transcriptome-wide maps of sites of 
specific RNA modifications, such as m6A, m1A, pseudouridine and m5C, means that it 
would also be interesting to also extend the CRAC pipeline to enable the overlap 
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between the cross-linking sites of a particular protein and the known sites of RNA 
modification to be automatically determined.  
 
4.2 The YTH domain-containing proteins associate with different 
RNA substrates and perform diverse cellular functions 
RNA modifications often influence RNA secondary structure and thereby can exert a 
stabilising or destabilising effect on the modified RNAs. Alternatively, RNA modifications 
can contribute to the function of the RNA, for example, RNA modifications in the 
anticodon of tRNAs can increase the decoding capacity of the tRNAs. Excitingly, as well 
as these direct influences of modifications on the functions of RNAs, it has recently 
emerged that RNA modifications can be recognised by specific proteins, termed 
“readers”, and that binding of such proteins to modified RNAs can affect the cellular fate 
of such RNAs. This concept now extends beyond recognition of the m7G cap at the 
5’ end of mRNAs by the cap binding complex of CBC20/CBC80 in the nucleus, which is 
essential for mRNA stability and export or recognition of this modification by eIF4E in the 
cytoplasm, which is required for mRNA translation (reviewed in Liu and Jia, 2014; 
Ramanathan et al., 2016). It was discovered that m6A modifications in cellular RNAs can 
be recognised and bound by the YTH protein domain, however, the binding of two other 
non-YTH domain-containing proteins to RNA substrates has also been found to be 
dependent on m6A modifications in the RNAs. HNRNPA2B1 recognises m6A modification 
in microRNA precursors and its binding regulates processing events (Alarcon et al., 
2015), while eIF3 promotes cap-independent translation and shows altered binding to its 
RNA substrates depending on the m6A modification (Meyer et al., 2015). 
The YTH domain protein family contains five members in humans and can be further 
divided into two subfamilies based on protein sequence similarity: YTHDF1, YTHDF2, 
YTHDF3, and YTHDC1 and YTHDC2. The CRAC approach, followed by bioinformatic 
analysis of obtain sequence reads, was applied to identify the RNA targets of all these 
YTH domain-containing proteins. This comparative analysis implied that YTHDF1, 
YTHDF2 and YTHDC1 predominantly associate with mRNA, which is in line with recently 
published data from the He, Pan and Yang labs (Wang et al., 2014a; Wang et al., 2015; 
Xiao et al., 2016), and similarly, YTHDF3 also seems to bind to mRNAs. The exclusively 
cytoplasmic localisation of all three YTHDF proteins (YTHDF1, YTHDF2 and YTHDF3) 
suggested that they associate with mature, rather than pre-mRNAs and indeed, YTHDF1 
was shown to be involved in enhancing the translation of specific mRNAs (Wang et al., 
2015) whereas YTHDF2 facilitates the localisation of certain mRNAs to p-bodies, thus 
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promoting their degradation (Wang et al., 2014a). The exact function of YTHDF3 is 
unknown so far, but sequence similarity to YTHDF1 suggests that it might perform a 
similar function on different mRNA substrates. Notably, YTHDF1 and YTHDF2 both bind 
to m6A modifications that are located near mRNA stop codons and interestingly, these 
proteins share approximately 50 % of their target RNAs (Wang et al., 2015). They are 
proposed to bind to these mRNAs at different time points to enable tightly regulated 
translation of these transcripts. It is suggested that first, YTHDF1 binds the m6A-modified 
mRNAs in order to promote their translation and then, YTHDF2 is recruited to efficiently 
deplete of these mRNAs resulting in an abrupt decrease in protein production.  
In contrast, YTHDC1 is a nuclear protein that was recently shown to act during mRNP 
biogenesis, by promoting alternative splicing of m6A containing pre-mRNAs in the 
nucleus via the interaction with several splicing factors (Xiao et al., 2016). 
Interestingly, in addition to interactions with m6A-modified substrate mRNAs, protein 
interaction partners have also been identified for YTHDF1, YTHDF2 and YTHDC1. 
Consistent with its function in promoting mRNA translation, YTHDF1 was shown to 
interact with the eukaryotic translation initiation factor eIF3 (Wang et al., 2015) and 
similarly, in line with its role in mRNA degradation, YTHDF2 interacts with components of 
the CCR4-NOT deadenylation complex (Du et al., 2016; Wang et al., 2015). Likewise, 
the splicing factors SRSF3 and SRSF10 were found to be protein interaction partners of 
YTHDC1 (Xiao et al., 2016). YTHDF1, YTHDF2, YTHDF3 and YTHDC1 are all relatively 
small proteins and sequence analyses suggest that in all cases, the only defined domain 
they contain is the YTH domain, which mediates interactions with the m6A modification in 
mRNAs. This suggests that the specific protein-protein interactions formed by these 
proteins are mediated by the divergent non-YTH domain regions of these proteins.  
In contrast to these proteins, YTHDC2 is a much larger protein that in addition to the YTH 
domain, also contains an R3H RNA-binding domain and a helicase core domain that 
contains two predicted ANK repeats (UniProt, 2015), a motif that is implicated in 
mediating protein-protein interactions (reviewed in Sedgwick and Smerdon, 1999).  
This implies that the RNA/RNP substrate(s), protein-protein interactions and mode of 
recruitment of YTHDC2 may differ considerably form the other members of the YTH 
domain protein family. 
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4.3 YTHDC2 associates with ribosomal complexes via an RNA 
binding motif 
In contrast to YTHDF1, YTHDF2, YTHDF3 and YTHDC1 that predominately associate 
with mRNAs, ribosomal RNA sequences were found to be enriched in the CRAC data of 
YTHDC2 compared to the control sample and sucrose density gradient centrifugation 
followed by western blotting confirmed that YTHDC2 co-migrates with ribosomal 
complexes. More specifically, a cross-linking site of YTHDC2 was found in the 18S rRNA 
sequence and notably, similar to the 18S rRNA m6A modification, this site is close to the 
3’ end of the rRNA. Further CRAC analysis using truncated forms of YTHDC2 suggested 
that this cross-linking is formed with the R3H domain of YTHDC2 and that this interaction 
is important for recruitment of YTHDC2 to the ribosome as lack of this domain reduced 
the fraction of rRNA sequences present in the CRAC data and decreased the height of 
the cross-linking peak at this position. However, no alteration in the CRAC profile 
compared to the full-length protein was observed when the YTH domain was lacking, 
implying that either this region of the protein cannot be efficiently cross-linked to bound 
RNAs or that this domain does not significantly contribute to the stable association of 
YTHDC2 with ribosomal complexes. Although the in vitro anisotropy data demonstrate 
that the YTH domain of YTHDC2 preferentially binds to m6A modified RNAs, the 18S 
m6A modification is likely not accessible on the surface of the mature ribosomal subunit 
(see Figure 13). This could suggest a model in which YTHDC2 is recruited to ribosomal 
complexes via its R3H domain and only once this stable association is formed, is the 
YTH domain positioned to probe for the presence of the m6A modification. The position 
of the 18S m6A modification within the ribosomal complex is likely in contrast to the 
majority of m6A modifications present in mRNAs and this alternative substrate may 
explain why an additional RNA binding domain is specifically required in YTHDC2, but 
not other YTH domain-containing proteins. Alternatively, it is possible that the association 
of YTHDC2 with ribosomes via its R3H domain also positions the YTH domain of 
YTHDC2 for recognition of m6A modification in other ribosome-associated RNAs, such 
as mRNAs. However, no specific mRNA targets of YTHDC2 could be identified within the 
CRAC data and the binding of the YTH domain of YTHDC2 to m6A modifications in the 
GG(m6A)CU sequence context, present in most mRNAs, is relatively weak (see also 
below). 
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4.4 The sequence context of m6A can affect recognition by the YTH 
domains 
Mapping of the m6A modifications in mRNAs and identification of an RNA binding motif 
for the known m6A methyltransferase complex comprised of METTL3, METTL14 and 
WTAP demonstrated that the majority of m6A modifications in mRNAs lie within a 
GG(m6A)CU sequence motif. Notably, in contrast to this, the m6A modifications present 
in both the 18S and 28S rRNAs are found in a different sequence context, UA(m6A)CA/G 
(Dominissini et al., 2012; Linder et al., 2015; Piekna-Przybylska et al., 2008a; Wei and 
Moss, 1977). The changes of G to U at -2 position, G to A at -1 and U to A or G at +2 
considerably alters the hydrogen bond capabilities of the nucleotides in the vicinity of the 
m6A modification and the charge of the local environment that, based on the available 
crystal structures of YTH domains together with m6A nucleosides, could be expected to 
have a significant effect on the binding of a YTH domain to the modified residue. Analysis 
of the affinities of the YTH domain of YTHDC2 for unmodified and m6A-modified RNAs 
confirmed that this domain preferentially binds to m6A-modified RNAs, however, 
compared to the YTH domains of YTHDF2 and YTHDC1, the affinity of the YTH domain 
of YTHDC2 for the RNAs containing the m6A modification in the GG(m6A)CU/mRNA 
motif was lower. This might be due to the fact that YTHDC2 possess an additional RNA 
binding domain (R3H) that stabilises interactions with its substrate RNA in vivo, meaning 
that unlike the other YTH domain-containing proteins, a high affinity for the modified 
residue is not required for the YTH domain-containing protein to exert its effect on the 
RNA. This idea is supported by comparison of the amino acid sequences of the human 
YTH domains (see Figure 19) and the available crystal structures of these domains.  
The RNA-interaction surface of the YTH domains of YTHDF2 (PDB 4RDN) and YTHDC1 
(PDB 4R3I) are more positively charged compared to the YTH domain of YTHDC2  
(PDB 2YU6), suggesting that the YTH domains of YTHDF2 and YTHDC1 may interact 
more strongly with the RNA backbone than that of YTHDC2. This may in turn facilitate 
the initial binding of the YTH domains to RNA and subsequently tighter binding to the  
N6-methylated residue once the modification is correctly positioned in the hydrophobic 
pocket of the YTH domain.  
However, the anisotropy data suggest that the sequence context of the m6A modification 
also influences the affinity of the different YTH domains. Although the YTH domain of 
YTHDC2 had a lower affinity for RNAs containing the GG(m6A)CU sequence than the 
YTH domains of YTHDF2 and YTHDC1, it bound more strongly to the UA(m6A)CA 
sequence found in the 18S rRNA. The higher affinity of the YTH domain of YTHDC2 for 
the m6A modification in the rRNA context supports the model in which YTHDC2 is 
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recruited to the ribosome to enable recognition of the m6A present on the rRNA. 
Interestingly, the YTH domains of YTHDF2 and YTHDC1 show the opposite effect with a 
lower affinity for the UA(m6A)CA/rRNA sequence than the GG(m6A)CU/mRNA sequence. 
This is especially notable for the YTH domain of YTHDC1, which shows a 10-fold 
increased affinity towards the m6A modification in the mRNA sequence compared to the 
modified rRNA sequence. An explanation for this differential binding may lie in the 
different localisations of the YTHDF2 and YTHDC1 proteins. On the one hand, YTHDF2 
is localised in the cytoplasm, where it will predominantly encounter mature ribosomes 
where the m6A modification is not readily accessible, meaning that discrimination 
between mRNA and rRNA is not necessary. On the other hand, YTHDC1 is localised in 
the nucleus, where it could interact with pre-ribosomal subunits that have a more open 
conformation and where the rRNA m6A modification may be exposed, making it 
advantageous to select against recognition of these modifications by having low affinity 
for the rRNA sequence context. Interestingly, the crystal structure of the YTH domain of 
YTHDC1 provides an explanation as to how this sequence discrimination is achieved  
(Xu et al., 2014). Analysis of the binding interface shows that the carboxyl oxygen of the 
guanine at the -1 position of the mRNA consensus motif can form hydrogen bonds with 
the secondary amine of the peptide backbone, stabilising RNA-protein interactions. 
Substituting this guanine with any other nucleotide would disrupt this hydrogen bonding 
and thereby decrease the binding to the RNA substrate. In particular, substitution to an 
adenine, which is present at the -1 position in the rRNA sequence context, would 
introduce steric clashes with the peptide backbone of YTHDC1, making substrates 
containing this sequence particularly unfavourable. 
 
4.5 YTHDC2 associates with the cytoplasmic 5’-3’ exonuclease XRN1 
Ribosomal RNA modifications are found in all kingdoms of life and in general are 
proposed to help stabilise the tertiary structure of the ribosome, enabling efficient and 
accurate translation. Consistent with this, rRNA modifications cluster at functionally 
important sites on the ribosome, such as the peptidyl transferase centre and the 
decoding site (reviewed in Sharma and Lafontaine, 2015). In yeast, no m6A modifications 
are present in the rRNAs, while in humans these modifications are present at positions 
1832 of the 18S rRNA and 4220 of the 28S rRNA (nucleotide numbering according to the 
human 80S ribosome structure, PDB 4V6X; Linder et al., 2015). It is not yet known what 
the specific functions of these modifications are, however, quantitative analysis of the 
extent of these modifications suggests that these sites are 98% modified in HeLa cells 
(Liu et al., 2013). This also suggests that the rRNA m6A modifications are not targeted by 
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the demethylases ALKBH5 and FTO that have been shown to reverse m6A modification 
in mRNAs (reviewed in Liu and Jia, 2014).  
To gain insight into the role of YTHDC2 on the ribosome and a possible function in 
recognition of the m6A modification in the 18S rRNA, immunoprecipitation experiments 
followed by mass spectrometry were performed to identify protein interaction partners, as 
in the case of the other YTH domain-containing proteins YTHDF1, YTHDF2 and 
YTHDC1 such analysis provided functional information. This revealed that YTHDC2 
interacts with the cytoplasmic 5’-3’ exonuclease XRN1 (see also Figure 24). Further 
immunoprecipitation experiments suggested that XRN1 interacts with the central region 
of YTHDC2, as neither the R3H domain nor the YTH domain were required for this 
interaction. The central region of YTHDC2 contains two predicted ANK repeats, which 
are protein interaction motifs that may allow YTHDC2 to form protein-protein interactions 
with XRN1. Interestingly, XRN1 has an extended C-terminus, which is not conserved in 
the related, nuclear 5’-3’ exonuclease XRN2 and which is suggested to serve as a 
protein-protein interaction domain in yeast (Chang et al., 2011). It is therefore possible 
that this region of XRN1 is involved in the interaction with YTHDC2 and that XRN1 is 
recruited to its numerous RNA substrates in the cytoplasm by various adaptor proteins, 
including YTHDC2. 
Since XRN1 is the major exonuclease component of the cytoplasmic RNA degradation 
machinery, this suggests that recruitment of YTHDC2 to the ribosome or to m6A-
containing RNAs may be linked to RNA surveillance or RNA turnover. In the context of 
the ribosome, in yeast, Xrn1 is linked to two related RNA decay pathways: no-go decay 
(NGD) in which aberrant mRNAs that are stalled on the ribosome during translation 
elongation are degraded and non-functional ribosome decay (NRD) where defective 
ribosomes are removed (reviewed in Graille and Seraphin, 2012; Lafontaine, 2010).  
It is possible that YTHDC2 contributes to either of these pathways by recruiting XRN1 to 
either aberrant ribosomes or to ribosomes that are blocked in translation. In support of a 
hypothesis that YTHDC2 recruits to aberrant ribosomes for NRD is that the misfolded 
ribosomes in which the rRNA m6A modification(s) are readily accessible may be detected 
by the YTH domain of YTHDC2 and thereby targeted for degradation by XRN1. 
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The pathway of NRD is poorly characterised in human cells but in yeast, both NRD and 
NGD are known to involve the protein Dom34 and Hbs1, which are also conserved in 
humans (Passos et al., 2009; Shoemaker et al., 2010). Since neither of these proteins 
was identified in the mass spectrometry analysis of YTHDC2-containing complexes, this 
could suggest that the YTHDC2-XRN1 complex functions independently in such 
pathways. In yeast, the pathway of NRD has mostly been studied using rRNA reporters 
that carry mutations in functional regions of the rRNA and which are expressed from an 
RNA polymerase II driven promoter (Cole et al., 2009; LaRiviere et al., 2006). However, 
expression of rRNAs in such a way has additional effects on ribosome assembly and due 
to the increased complexity of pre-rRNA transcription in human cells, such a system is 
currently not available to study the NRD pathway in human cells.  
Alternatively, YTHDC2 may also function in NRD by monitoring the presence of the m6A 
modification on the rRNA and directing ribosomes lacking this modification for 
degradation since the absence of this modification may have negative effects on 
translation fidelity or efficiency. Notably, another specific feature of the YTHDC2 domain 
architecture is the presence of an RNA helicase domain. RNA helicases are a 
ubiquitously expressed family of proteins that can unwind RNA duplexes in an ATP-
dependent manner. Most RNA helicases can be classified as either DEAD- or DEAH-box 
proteins based on the presence of a conserved sequence motif. DEAD- and DEAH-box 
helicases are distinct in their RNA unwinding mechanism (reviewed in Jarmoskaite and 
Russell, 2014). DEAD box helicases perform local strand unwinding whereas DEAH box 
helicases are processive and can move along an RNA strand while unwinding other base 
paired RNA strands. YTHDC2 is predicted to belong to the family of DEAH box RNA 
helicases and an earlier study reported an RNA dependent ATPase activity of the  
C-terminal part of the protein consisting of the amino acids 761-1430 (Morohashi et al., 
m6A
XRN1
YT
H
D
C
2
YTH
R3
H
LSU
SSU
Figure 24 Model of YTHDC2 ribosome 
association. YTHDC2 in complex with the 5’-3’ 
exonuclease XRN1 interacts with the ribosome via 
the R3H domain and the YTH domain is probing 
for the 18S rRNA m6A modification in the SSU. 
The R3H domain, helicase core domain and YTH 
domain of YHTDC2 are coloured in red, green and 
blue, respectively. Abbreviations: LSU, large 
ribosomal subunit, SSU; small ribosomal subunit 
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2011), implying that YTHDC2 is an active RNA helicase although further experiments 
using the full-length protein or complete helicase core domain would be required to 
confirm this. It is possible, therefore, that the helicase activity contributes to rRNA 
remodelling in the vicinity of the rRNA m6A modification(s) to enable the YTH domain of 
YTHDC2 to detect the presence of these modifications in vivo. The helicase domain of 
YTHDC2 may also be required for efficient RNA degradation by XRN1 as this 
exonuclease is not very active on highly structured substrates (e.g. ribosomal RNAs) 
(Poole and Stevens, 1997). A complex containing XRN1 and the helicase DDX6 is used 
in 5’-3’ mRNA degradation, where the helicase might unwind secondary structures prior 
to degradation by XRN1 (Ozgur et al., 2010) as it is the case in 3’-5’ RNA degradation by 
the exosome. RNA helicases unwind mRNA secondary structures ahead of the exosome 
and channel the RNA into the exosome for degradation (reviewed in Schneider and 
Tollervey, 2013). 
 
5 Conclusion 
RNA modifications play diverse and important roles in regulating the functions of the 
RNAs that carry them. Furthermore, RNA modifications in cellular RNAs can be 
specifically recognised by proteins termed “readers” that bind to the modified nucleotides 
and regulate the fate of the modified RNA. In humans, the five YTH domain proteins bind 
to RNAs containing m6A modifications and mediate diverse functions. In line with recently 
published data, CRAC analysis showed that YTHDF1, YTHDF2, YTHDF3 and YTHDC1 
were found to predominantly associate with mRNAs, which in contrast YTHDC2 was 
found to be associated with ribosomal complexes and to cross-linking to the 18S rRNA in 
proximity to an m6A modification. In vitro anisotropy experiments demonstrated that, 
unlike the YTH domains of YTHDF2 and YTHDC1, the YTH domain of YTHDC2 has a 
higher affinity for m6A modifications in the sequence context present in the rRNA rather 
than the classical m6A consensus motif found in many mRNAs implying that it may 
recognise the 18S rRNA m6A modification. Furthermore, YTHDC2 was found to interact 
with the 5’-3’ exonuclease XRN1 suggesting that YTHDC2 may serve as an adaptor 
protein to target m6A-containing RNAs for degradation. 
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